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ABSTRACT OF DISSERTATION

NEUROCHEMICAL FACTORS ASSOCIATED WITH THE INITIAL
PATHOPHYSIOLOGICAL REACTION TO LARGE VESSEL OCCLUSION STROKE
Ischemic stroke is the leading cause of disability world-wide and affects over
800,000 people per year in the United States. The majority of these strokes are ischemic
due to a blockage of blood flow to the brain. Damage to the brain occurs at the onset of
stroke, neuronal cell death is irreversible and therefore, quick treatment to remove
blockage is critical factor in the recovery from stroke. Mechanical thrombectomy as a
treatment for ischemic stroke provides an ideal opportunity to collect blood distal and
proximal to the cerebral thrombus to examine neurochemical changes occurring during
stroke.
The purpose of this dissertation was to explore the trajectory of neurochemical
changes that occur in response to ischemic stroke during the first 72 hours and the
physiological response from stroke patients to improve stroke outcomes. The specific
aims were to: 1) to determine whether venous blood gases predict infarct volume and/or
mortality in acute ischemic stroke in young male rats; 2) determine whether venous blood
gases predict infarct and edema volume, and/or mortality in acute ischemic stroke in aged
male and female rats; 3) compare the presence and relative concentrations of acid/base
and electrolytes in static blood distal to thrombus and in peripheral blood drawn from
adults who received thrombectomy for ischemic stroke and identify associations to postreperfusion functional outcomes.
Specific Aim One was addressed by evaluation of young (three-month old)
Sprague-Dawley rats that underwent permanent or transient middle cerebral artery
occlusion (MCAO). Pre- and post-MCAO venous samples from permanent and transient
models provided pH, carbon dioxide, oxygen, bicarbonate, glucose, hematocrit,
hematocrit, and electrolyte values of ionized calcium, potassium and sodium. The
analyses indicated that mean differences in the blood gas and electrolytes between pre- to
post-MCAO and pH and iCa2+ were predictors of infarct volume in the permanent
MCAO model. The second aim was addressed by evaluation of aged (18 month old) male
and female rats pre-MCAO, post-MCAO, and at 72 hours of permanent MCAO venous

blood gas samples (pH, carbon dioxide, oxygen, bicarbonate, glucose, hematocrit,
hematocrit, and electrolyte concentrations of ionized calcium, potassium and sodium).
Changes in pH (from pre-MCAO to post-MACO and post-MCAO to 72 hours) and
changes in Na+ and iCa2+ (from post-MCAO to 72 hours) were predictors of infarct
volume and edema volume, respectively in both sexes. Cox regression revealed there was
a 3.25 times increased risk for mortality based on changes (cut-off range within -2.00 to 7.00) in bicarbonate levels (pre- to post-MCAO). The third aim was addressed by
evaluation of acid/base balance (pH, carbon dioxide, oxygen, bicarbonate, ionized
calcium, potassium and sodium) of ischemic stroke patients who underwent mechanical
thrombectomy. Our results suggests sex differences matter in ischemic stroke
populations. Significant differences occur within proximal blood between the sexes.
Additionally, females had approximately 2.5 hour increased time between stroke
symptom onset to thrombectomy completion time (described as infarct time). Changes in
bicarbonate and base deficit were predictors of infarct time, but only in our female
population.
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CHAPTER 1. INTRODUCTION
Background
Ischemic stroke is the leading cause of disability in the United States and affects
over 800,000 Americans per year [1]. It is the third leading cause of death for women,
occuring in about 55,000 more women than men each year [1]. African Americans have
twice the risk of having a first stroke when compared with Caucasians, in addition to an
increased mortality rate from stroke [1]. In Kentucky, stroke is the fifth leading cause of
mortality [2]. Given the pervasiveness of stroke, it is critical to develop a more complete
understanding of the pathophysiology at the time of stroke onset; these insights may
reveal potential targets for stroke treatment.
The majority of strokes (87%) are ischemic and result from a thrombus
obstructing a major artery in the brain [1]. The blockage caused by the thrombus
produces initial hypoxic damage that is followed by ischemia and inflammation [3, 4]. As
neurons die, they produce an infarct core. The penumbra, the area surrounding the infarct,
also includes neurons and tissue at risk of cell death, and will expand to adjacent neurons
if reperfusion does not occur [5]. Shifts occur within the cerebral blood flow (CBF)
leading to disturbances in brain metabolism. Water, ionic concentrations, and other
biochemical properties begin to change due to the obstruction and the decreasing CBF.
Disruption in blood flow reduces oxygen (O2) and glucose, and leads adenosine
triphosphate (ATP) to be mismatched with use and production [6]. Oxygen availability to
the brain is the product of CBF and the O2 content of arterial blood. Cerebral ischemia
occurs when metabolic demand for O2 is not met.
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The presence of the thrombus decreases CBF resulting acidosis due to a lack of
glucose and an increase in carbon dioxide (CO2). A lack of glucose triggers cellular
glycolysis increasing of lactic acid production and a lowering in pH disrupting normal
acid/base balance within the brain [7, 8]. During ischemia, CO2 from neural cells
accumulate in intracellular spaces, which lead to a further reduction in pH levels [9].
When blood pH decreases, electrolyte concentrations of sodium (Na+), calcium
(Ca2+) and potassium (K+) which maintain cellular structure and function are affected [6].
Dysregulation of ion gradients within neuronal cell membrane transport system occurs in
Na+/K+ and Na+/Ca2+ pumps. Under normal conditions Na+ is pumped out of the cell and
K+ into the cell, but without a supply of ATP, the pump stops working properly. The
increased concentration of intracellular Na+ leads to cytogenic edema. The disruption of
the Na+/Ca2+ pump leads to an increased concentration of intracellular Ca2+, which is
detrimental in several ways [10]. It causes excitotoxicity by the release of glutamate
neurotransmitters, which spurs neighboring neurons to also become overexcited. It also
activates lipases that break down neuron cell membranes allowing other ions to enter the
neuron. Finally, this process produces an increase of cytoplasmic calcium causing
mitochondrial dysfunction, leading to the generation of free radicals and reactive oxygen
species (ROS) that are responsible for neural cell death [10].
These initial pathophysiological changes can produce irreversible neuronal cell
death and therefore, time is critical in the treatment of stroke. Current treatments break up
or remove the thrombus using tissue plasminogen activator (tPA) and/or mechanical
thrombectomy [11-13]. tPA catalyzes the conversion of plasminogen to plasmin and is
the primary mechanism for thrombolysis. The use of intravascular tPA is time dependent
2

and patients can only be administered tPA within 4.5 hours after stroke onset. Mechanical
thrombectomy is an intraarterial procedure to remove a thrombus and re-establish blood
flow for emergent large vessel occlusions (ELVO) [14, 15]. Recently, the American
Heart Association/American Stroke Association changed the time window for
mechanical thrombectomy; the recommendation moved from a 6-hour treatment window
to 24 hours [16-18].
Interestingly, thombectomy has also provided researchers with a rare opportunity
to examine neurochemical changes that occur during stroke. It allows researchers to
isolate blood within the artery immediately distal and proximal to the thrombus (systemic
arterial blood in the cervical carotid artery) [19]. The analysis of these blood samples
may help us better understand early neurochemical changes after stroke onset to assist in
the development of adjunctive therapies to compliment current stroke treatments.
Acid/Base Balance and Electrolyte Concentration in Large Vessel Occlusion
Researchers have examined the relationship of venous and arterial blood gas
parameters in critically ill patients [20-25] and in rodent models [26, 27]. These studies
demonstrate that venous blood gas values in rodents and humans are similar and therefore
comparable. Flores et al. (2011) examined arterial blood gases and electrolyte
concentrations in distal blood adjacent to the cerebral thrombus and peripheral blood
from the carotid artery during mechanical thrombectomy of ischemic stroke patients (n =
16), with results indicating significant differences between the two blood samples in
partial pressure oxygen (distal 73.9 ± 14.9 and proximal 78.9 ± 16.3, p = 0.007) and
oxygen saturation (distal 93.2 ± 4.4 and proximal 94.3 ± 3.9, p = 0.003) [28]. Back et al.
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(2000) assessed pH regulation in rodents within 30 minutes and six hours of permanent
middle cerebral artery occlussion (MCAO) model. They found acidosis (pH = 6.03) in
the infarct core and alkalosis (pH = 7.32) in the penumbral area [8]. Together, these
studies provide initial insights into acid/base balance and electrolyte concentrations. The
gap in the knowledge is that we do not have blood gas values at baseline or stroke onset
in large vessel occlusion and how these contribute to subsequent physiological changes
like infarct and edema volumes and eventually outcomes. This study uses larger sample
sizes of both rodent models and individuals diagnosed with ischemic stroke to examine
associations of blood gases and electolyte concentrations to infarct and edema volumes,
mortality, and infarct time.
Researchers have also examined electrolyte changes that occur during stroke. A
lowering in total serum calcium concentrations in peripheral venous blood in stroke
patients were associated with more severe clinical symptoms following stroke onset,
including worse functional outcomes and an ishemic stroke to hemorrhagic conversion
after thrombectomy [29-31]. Higher total serum calcium levels from peripheral venous
blood were detected on patient admission or within 24 hours of stroke onset were
associated with improved functional outcomes and decreased infarct volumes [32-34].
Serum Na+ levels from peripheral venous samples were associated with stroke severity
but the results are inconclusive. Rodrigues et al. [35] and Soiza et al. [36] found patients’
with lower sodium levels or hyponatremia were associated with increased stroke severity
and risk for mortality. Others have observed higher venous serum sodium concentrations
were associated with stroke incidence and neurological worsening [37-39]. Serum Na+
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levels in the healthy group of controls were lower than in patients with transient ischemic
attack and with ischemic and hemorrhagic strokes [40].
Purpose and Overview of Dissertation
The purpose of this dissertation was to explore the trajectory of neurochemical
changes that occur in response to large vessel occlusion during the first 72 hours in
rodent models and from ischemic stroke patients to improve stroke outcomes. The aims
of dissertation were to: 1) to determine whether venous blood gases predicted infarct
volume and/or mortality in acute ischemic stroke in young male rats; 2) determine
whether venous blood gases predicted infarct volume, edema volume, and/or mortality in
acute ischemic stroke in aged male and female rats; 3) compare acid/base balance and
electrolytes in static blood distal to thrombus and in peripheral circulation drawn from
adults who received thrombectomy for ischemic stroke and identify associations to postreperfusion outcomes (infarct and edema volumes, and infarct time), after controlling for
gender, BMI, and admission National Institutes of Health Stroke Scale NIHSS.
To date, no other study has examined acid/base balance and electrolyte changes
this early after occlusion in permanent and transient-MCAO rat models or examined
these changes in aged male and female rats. In addition, this is the first time these
changes were tested as predictors of infarct volume, edema volume, and/or mortality in
rats. We also evaluated blood gas and electrolyte values in the distal and peripheral blood
adjacent to the cerebral thrombus at early time points after stroke in humans. These
findings will aid in reverse translation from human to rodent models, so stroke models
can focus on the most appropriate clinical endpoints and patient population. The results
of this dissertation will increase our knowledge of stroke pathology and assist in
5

optimizing translational research seen in both rodent models and in humans. This work
has the potential to fundamentally change how we develop treatment strategies for the
stroke patient population.
Chapter Overviews
Chapter Two is a descriptive correlational design assessing acid/base balance (pH,
carbon dioxide, oxygen, bicarbonate, base excess, glucose, hematocrit, and hemoglobin)
and electrolyte concentrations (ionized calcium, potassium and sodium) changes that
occur within a few minutes of focal ischemia in permanent middle cerebral artery
occlusion (MCAO) and transient MCAO stroke models in young (three-month-old) male
rats. The gap in the knowledge is that we do not have literature comparing acid/base and
electrolyte concentrations in two focal ischemia models. These animal models mirror two
stroke situations – a patient receiving stroke treatments and the natural history of a stroke
patient. Additionally, there is no existing literature that evaluates early acid/base and
electrolytes in focal ischemia and uses these values for predictors of stroke outcomes
(infarct volume and/or mortality). Data from these models were analyzed using paired
samples t-tests, Kaplan-Meier survival curve, and multiple linear regression analyses.
This chapter is a published manuscript, Translational Evaluation of Acid/Base and
Electrolyte Alterations in Rodent Model of Focal Ischemia, in Journal of Stroke and
Cerebrovascular Diseases (JSCVD) (published 08/03/2018) [41].
Chapter Three reports a descriptive correlational study of acid/base balance and
electrolyte changes occurring within a few minutes of focal ischemia and occlusion in the
permanent middle cerebral artery occlusion (MCAO) model in aged (18-month-old) male
and female rats. The blood gases were collected 1) pre-MCAO, 2) post-MCAO
6

(approximately seven minutes) and at 3) 72 hours post-MRI and prior to euthanization.
The gap in the knowledge is that most stroke studies use young male rats as their
population, and this does not reflect the age or sex balance of the patient population that
suffers from strokes. This study included aged male and female rats to evaluate early
acid/base and electrolyte values, as well as to determine predictors of infarct volume,
edema volume, and mortality in older animals. Additionally, we compared our results to
those reported in Chapter Two, and assessed the sex differences in our aged animals.
Data from these models were analyzed using a one-way repeated measures ANOVA,
multiple linear regression, and Cox regression analyses. This chapter is a published
manuscript, Early Acid/Base and Electrolyte Changes in Permanent Middle Cerebral
Artery Occlusion: Aged Male and Female Rats, in the Journal of Neuroscience Research
(JNR) on 4/4/2019 [42].
Chapter Four reports a descriptive correlational design study of acid/base and
electrolyte concentrations in distal and proximal arterial blood (relative to the thrombi)
from ischemic stroke participants at the time of mechanical thrombectomy. The gap in
the knowledge is that there is little evidence of arterial blood gases at the time of
ischemic stroke and during mechanical thrombectomy, especially related to sex
differences. This study compares acid/base balance and electrolyte concentrations
between male and female ischemic stroke participants. Additionally, we were interested
in predictors of stroke outcomes and infarct time, and whether these were sex dependent.
The data for this study were analyzed using a one-way repeated measures ANOVA and
moderated multiple linear regression. This manuscript, Evaluation of Sex Differences in
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Acid/Base and Electrolyte Alterations in Acute Large Vessel Occlusion is in preparation
for the submission to Journal of Neurointerventional Surgery (JNIS).
Chapter Five is a discussion of how each manuscript contributes to the state of the
science on large vessel occlusion stroke. In addition, there is a discussion of the
limitations, clinical implications, and future directions for research based on this work.
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CHAPTER 2. TRANSLATIONAL EVALUATION OF ACID/BASE AND ELECTROLYTE
ALTERATIONS IN RODENT MODELS OF FOCAL ISCHEMIA

Abstract
Background and Purpose: Acid/base and electrolytes could provide clinically valuable
information about cerebral infarct core and penumbra. We evaluated associations
between acid/base and electrolyte changes and outcomes in two rat models of stroke,
permanent and transient middle cerebral artery occlusion.
Methods: Three-month old Sprague-Dawley rats underwent permanent or transient
middle cerebral artery occlusion. Pre- and post-middle cerebral artery occlusion venous
samples for permanent and transient models provided pH, carbon dioxide, oxygen,
glucose, hematocrit, and hemoglobin, and electrolyte values of ionized calcium,
potassium and sodium. Multiple regression determined predictors of infarct volume from
these values, and Kaplan-Meier curve analyzed morality between permanent and
transient middle cerebral artery occlusion models.
Results: Analysis indicated significant differences in the blood gas and electrolytes
between pre- to post-middle cerebral artery occlusion. A decrease in pH and sodium with
increases in carbon dioxide, potassium, ionized calcium, and glucose changes were found
in both middle cerebral artery occlusion models; while hematocrit and hemoglobin were
significant in the transient model. pH and ionized calcium were predictors of infarct
volume in the permanent model, as changes in pH and ionized calcium decreased, infarct
volume increased.
Conclusion: There are acute changes in acid/base balance and electrolytes during stroke
in transient and permanent rodent models. Additionally, we found pH and ionized
calcium changes predicted stroke volume in the permanent middle cerebral artery
9

occlusion model. These preliminary findings are novel, and warrant further exploration in
human conditions.
Introduction
Approximately 87% of strokes are ischemic, and are characterized by blockage of
blood flow in the brain from a thrombus or embolus [1]. Neurological insult occurs
immediately when the cerebral artery is occluded, as neural tissue is deprived of
oxygenated blood, glucose, and other nutrients [2]. The penumbra, the area surrounding
the infarct, also includes tissue at risk of cell death, and will expand to adjacent areas if
reperfusion does not occur [2]. When there are instabilities in cerebral blood flow (CBF),
disturbances in brain metabolism occur, causing shifts in water and ion concentrations.
With decreasing CBF, the blood downstream of the occlusion undergoes biochemical
changes. Disruption in blood flow reduces oxygen (O2) and glucose, and leads adenosine
triphosphate (ATP) to be mismatched with use and production [3]. Cerebral ischemia
occurs when cerebral O2 supply fails to meet cerebral metabolic demand. Reduction in
CBF causes lactic acid and carbon dioxide (CO2) accumulation [4-6]. Furthermore,
electrolyte concentrations such as sodium (Na+), calcium (Ca2+) and potassium (K+) are
sensitive to pH changes to maintain cellular structure and function [3]. Dysregulation is
additive, as disruption of the Na+/Ca2+ pump leads to an increased concentration of
intracellular Ca2+ [7]. Increased calcium can trigger apoptosis, depolarization that
activates lipases to break down neuron cell membranes, and mitochondrial dysfunction,
leading to the generation of free radicals and reactive oxygen species (ROS) [7].
Several studies have investigated the relationship of venous and arterial blood gas
parameters in critically ill human patients [8-13], and in rodent models [14, 15]
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demonstrating correlations between the blood gas values. Knowledge of blood gases
could provide clinically valuable information about the cerebral infarct core and
penumbra. To date, few studies have evaluated acid/base balance and electrolyte changes
occurring within a few minutes of focal ischemia and occlusion. The aim of our study
was to evaluate these changes, and use these changes as predictors of infarct volume
and/or mortality in two different rat models of stroke: permanent middle cerebral artery
occlusion (MCAO) and transient MCAO. The permanent-MCAO model would mimic
the natural history of large vessel occlusive stroke, while the transient-MCAO model
accounts for recanalization seen in current treatment states that aim to re-establish flow.
Materials and Methods
Permanent and Transient MCAO Model
Three-month old Sprague-Dawley rats (ENVIGO, Indianapolis, IN) were used for
all procedures. The rats weighed between 300 and 350 grams. The study was conducted
in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals and study protocols were approved through our Institutional Animal
Care and Use Committee (IACUC). Animals were kept in a climate controlled room on a
12-hour light and dark cycle (0700 - 1900) with free access to food and water. For both
models, animals were administered vehicle of phosphate buffered saline (PBS) at 7.4, at
6, 24, and 48 hours after MCAO.
For the permanent middle cerebral artery occlusion (pMCAO) procedure, as
previously described [16], animals were placed in an induction chamber and anesthetized
with 5% isofluorane/oxygen. A constant flow of 3 - 4% isofluorane in 100% oxygen at a
rate of 1 L/min was maintained during the procedure. A vertical incision was made near
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the sternum to expose the right common carotid artery, and then a dissection was
performed to isolate the common carotid and its branches. The first clamp was placed on
the internal carotid prior to the pterygopalatine/internal cerebral artery (ICA) bifurcation,
while the second clamp was placed on the common carotid artery. The placement of the
second clamp further in the posterior direction allows more room for maneuvering during
filament insertion. The external carotid was isolated, and used to access the arterial
system. A 40mm nylon monofilament was fed distally into the intracranial artery to
approximately 25mm, and then sutured in place to obtain permanent occlusion of the
middle cerebral artery (MCA), M1 segment. The incision was closed with the filament
in-place. A Laser Doppler (Moore Lab Instruments, Farmington, CT) monitored blood
flow during the process. Animals that did not show 60% reduction in perfusion of blood
flow after placement of the monofilament were excluded from the study. The transient
MCAO (tMCAO) followed the same procedure, but the monofilament was removed and
flow re-established after 60 minutes. The transient-MCAO rats (n = 19) were euthanized
at 72 hours. The permanent-MCAO rats were euthanized at either 72 (n = 7) or 96 hours
(n = 11). Brains from both models were harvested for infarct measurements.
Blood gas samples were collected and analyzed pre- and post-MCAO. An internal
jugular line was inserted, prior to MCAO monofilament placement but after anesthesia
induction, and an approximately 0.5mL of venous blood sample was collected
(representing the pre-MCAO sample). These venous systems of the brain drains into the
sinus of confluence which splits to form the internal jugular veins, which is the final
collecting port before returning to the heart [17]. The majority of the venous blood
samples were drawn on the ipsilateral side (affected MCAO side) of the animal. When
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the blood samples at the affected site were unable to be obtained, the blood draw
occurred on the contralateral side (unaffected MCAO side). While the ipsilateral side
location is preferred for consistency in our blood draw protocol, the blood is analogous
due to the venous anatomy. It takes approximately 30 minutes to obtain the blood sample
given the details of the MCAO procedure and anesthesia induction (represented by the
shaded box for the variable time points, Figures 2.1 and 2.2). The sample was analyzed
using iSTAT Portable Clinical Analyzer (Abbott Laboratories, Abbott Park, IL). After
pMCAO (approximately seven minutes), rats remained anesthetized on the operating
table and venous blood sample was again collected (representing the post-MCAO
sample) and analyzed with the iSTAT. pH, carbon dioxide (pCO2), oxygen (pO2),
bicarbonate (HCO3-), base excess of extracellular fluid (beecf), glucose, and serum
electrolytes, including ionized calcium (iCa2+), potassium (K+), and sodium (Na+) were
analyzed. In the case of permanent MCAO, the post-MCAO sample was taken on
average seven minutes after induction of the MCAO, while, in the case of the transient
MCAO, the post-MCAO sample was taken approximately one hour and seven minutes
after MCAO.
Euthanasia and Tissue Preservation
Animals were euthanized with Ketamine and Xylazine mixture (75 mg/kg and 7.5
mg/kg), at 72 or 96 hours after MCAO. They were perfused with 0.9% saline, then with
4% paraformaldehyde in PBS to remove blood from circulation and to preserve tissue.
Brains were harvested in 4% paraformaldehyde, and then shifted to 20 to 30% sucrose for
cryopreservation. Six coronal brain sections were cut (30µm) with a cryostat and taken
from +1.7 to -3.3mm bregma coordinates. Coronal sections were mounted on glass slides
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and stored at −20°C. To label degenerating neurons Fluoro-Jade staining (Histochem,
Jefferson, AR) was used. This method has been previously detailed [18]. To rehydrate the
coronal sections, 100% ethanol was used for three minutes, followed by a minute each in
70% ethanol and deionized water. Sections were then Fluoro-Jade stained (0.001%
solution in 0.1% acetic acid) for 30 minutes. Slides were rinsed and dried at 45°C for 20
minutes, and then coverslipped with DPX mounting medium (Electron Microscopy
Sciences, Ft. Washington, PA).
Infarct Volume Analysis
Coronal brain sections (bregma coordinates +1.7 through −3.3mm) were collected
from rats in both models. A Zeiss AxioSkop2 microscope (model 801572) with a Zeiss
AxioCam Color camera (model 412-312, Oberkochen, Germany) was used with
OpenLab imaging software (Improvision Ltd., Lexington, MA) to capture images. Total
infarct volumes were measured with NIH Image J software by taking the damaged
ipsilateral hemisphere and dividing the total area of the contralateral hemisphere (six
sections of each brain) measurement and multiplying by 100 to obtain a percentage.
Infarct volume measurement equation: ipsilateral/contralateral x 100 = percentage.
Statistical Analyses and Sample Size
Before conducting statistical analyses, variables were transformed to meet
assumptions of normality. Data from both MCAO models were analyzed using SPSS,
version 24 software (SPSS, Inc., Chicago, IL). Data analysis began with a descriptive
examination of all variables, including frequency distribution, means, and standard
deviations. Paired samples t-tests were used to compare venous blood gas differences in
mean scores between pre- and post-MCAO samples. Multiple linear regression with
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backward variable entry was performed in the permanent and transient models to
determine predictors based on venous blood gas and electrolyte changes to infarct
volume. The variables were entered into the model at once. The adjusted R2 was used to
determine the variance explained in infarct volume. The P-to-P plot was used to assess
the changes in pH and iCa2+ data sets for normal distribution. Multicollinearity was
assessed by examining correlation coefficients and tolerance/variance inflation factor
values. A Kaplan-Meier curve using Mantel-Haenszel log-rank test analysis was
performed to analyze mortality between permanent and transient-MCAO models. A pvalue of 0.05 was set a priori to determine statistical significance.
The total sample size for the permanent MCAO model was 18. These animals are
furthered categorized into those that survived to 72 hours (n = 11), and those that died
prior to 72 hours (n = 7). In comparison, the total sample size for transient MCAO was
19. These animals are also divided into those that survived to 72 hours (n = 17), and those
that died before 72 hours (n = 2). Total sample size for both models was reduced during
the iSTAT blood sample collection due to individual readings errors. Errors were
excluded from statistical tests.
Results
Relationship Between MCAO Model and Mortality
A Kaplan-Meier curve and Mantel-Haenszel log-rank test was used to analyze
event-free survival between permanent and transient MCAO models (p = 0.045).
Approximately 39% mortality was seen in the permanent model, while an average of
11% occurred in the transient model. The mortality rates were collected at four different
time points; 6 hours, 24 hours, 48 hours, and 72 hours. In the permanent model (n = 18),
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seven rats died at 24 hours and 11 rats survived up to 72 hours. By comparison, the
transient model (n = 19) rats exhibited greater survival, with one death at 6 hours and one
other at 24 hours; the remaining animals (n = 17) survived up to 72 hours (Figure 2.3).
The permanent-MCAO infarct volumes ranged from 24.40 to 90.79% (Figure 2.4). The
transient-MCAO infarct volumes ranged from 12.07 to 33.34% (Figure 2.5). There is no
significant difference in infarct size between transient and permanent occlusion.
Permanent MCAO Model
In the permanent MCAO model, there were several significant differences in the
blood gas analysis between pre- and post-MCAO (Figure 2.6). These included significant
decrease in pH (p = 0.035), Beecf (p = 0.001), and Na+ (p < 0.001), as wells as increases
in pCO2 (p = 0.036), K+ (p = 0.006), iCa2+ (p = 0.045), and glucose (p < 0.001). Multiple
regression analysis in the permanent-MCAO model (n = 11) showed that the changes in
pH and in iCa2+ were significant predictors of infarct volume (F (2,8) = 16.582, p =
0.001). This indicates a negative coefficient between pH and ionized calcium together
with the extent of the infarct, as changes in pH and calcium decreased, infarct volume
increased. These variables explained 76% of the total variance in the model, as predictors
of infarct volume (Figure 2.7 and 2.8).
Transient MCAO Model
In the transient MCAO model, there were also several significant differences in
blood gas analysis between pre- and post- MCAO (Figure 2.9). These included decreases
in pH (p = 0.004) and Na+ (p = 0.002), as well as increases in pCO2 (p = 0.024); K+ (p <
0.001), iCa2+ (p = 0.015), glucose (p = 0.047), hematocrit (p < 0.001), and hemoglobin (p
< 0.001). Unlike the permanent model, Beecf (p = 0.397) was not significantly altered.
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None of the acid/base changes or electrolyte changes in the transient-MCAO model were
predictors of infarct volume.
Discussion
To our knowledge our study demonstrates, for the first time, rapid changes in
venous blood gases and electrolytes occurring immediately following cerebral ischemia
in two separate MCAO rat models (permanent and transient). Furthermore, we establish a
statistically significant predictors between some of those changes and infarct volume.
Significant differences were seen between the two models for mortality. Our blood
analyses follow the biochemical changes reported in other cerebral occlusion studies in
animals and humans. We report that significant systemic changes in blood chemistry
occurs very rapidly after occlusion with an average of seven minutes in the permanent
MCAO model, and approximately one hour and seven minutes in the transient MCAO
model. To our knowledge, we have not found any other studies that examined these
changes so early after occlusion and in two separate MCAO models.
We used the permanent and transient MCAO models for two reasons. First, we
aimed to identify ultra-early changes in a permanent model of ischemia. While there are a
host of signaling cascades that occur in multiple pathways to induce injury, apoptosis,
and necrosis after stroke, we evaluated the relationship between these ultra-early changes
and eventual outcome. Second, we wanted to plot the course of blood gas and electrolyte
changes upon early reperfusion. As recanalization strategies such as tissue plasminogen
activator (tPA) and mechanical thrombectomy have become standard of care, it is
important to understand pathologic changes in stroke in the context of acute
recanalization. The permanent model is an evaluation of large vessel occlusive stroke in
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its natural history [19]. The majority of patients who experience an ischemic stroke do
not receive tPA and/or mechanical thrombectomy [20, 21]. The transient model is an
evaluation of the effect of treatment, because it mimics the human condition for receiving
tPA and/or mechanical thrombectomy and the reperfusion event. The transient model
evaluates the persistency of changes in acid/base and electrolytes immediately after
reperfusion.
This study combined all blood measurements to determine association with infarct
volume. In evaluating the early changes in acid/base and electrolytes in the permanent
model the multiple linear regression showed significance in changes of pH and iCa2+ to
infarct volume in the permanent model. These two variables clearly have an
interrelationship to infarct volume, but causality needs to be furthered evaluated in future
studies.
In human stroke patients, lower venous total serum calcium concentrations were
associated with more severe clinical symptoms following stroke onset, worse functional
outcomes, and hemorrhagic transformation post-thrombectomy [22-24]. Conversely,
higher venous total serum calcium levels detected on admission or within 24 hours of
stroke onset in acute ischemic stroke patients were associated with better functional
outcomes and reduced cerebral infarcts [25-27]. These findings reflect increased serum
calcium levels are linked to positive stroke outcomes. Our study indicates an inverse
relationship with changes in ionized calcium and infarct volume; however, this is based
on immediate ionized calcium (iCa2+) changes, not total calcium serum. Furthermore, our
measurements were within minutes to hours of the infarct induction, while the previous
studies above included levels drawn within 24 hours of admission. Therefore, there may
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be a calcium concentration curve that is temporal in nature as it relates to infarct. Further
temporal studies are needed to map this relationship.
While we found no predictors between changes in Na+ and infarct volumes,
several reports with contradictory results show serum Na+ levels are associated with
stroke severity in human patients. Rodrigues et al. [28] and Soiza et al. [29] found lower
sodium or hyponatremia was associated with stroke severity and mortality. Other studies
have observed higher venous serum sodium concentrations were associated with stroke
incidence and neurological worsening [30-32]. Serum Na+ levels in the control group was
lower than in patients with transient ischemic attack, and with ischemic and hemorrhagic
strokes [33]. Our findings are similar in showing changes in serum Na+ levels from pre-to
post- pMCAO, but the significance of these changes needs to be elucidated. Again, the
timing of sampling may have an effect on the power of the association. It may be the case
that our early-timed assay does not reflect changes that occur in the first 24 to 48 hours.
The transient MCAO model did not show predictors in the multiple linear
regression model. We believe this is due to the magnitude of the changes of acid/base and
electrolytes may be masked by the benefit of reperfusion. While we saw many similar
differences in changes from pre- to post-MCAO (compared to the permanent model), the
animals did not have any predictors of infarct volume. This may reflect the overpowering
effect of recanalization and reperfusion on dictating final infarct volume. Further studies
will need to be conducted to address these issues.
Another interesting difference between the two models was noting the significant
differences of increased hematocrit and hemoglobin pre- to post-MCAO in the transient
model, most likely due to hemoconcentration of fluid losses (urination, temperature or
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insensible losses), which is often seen in human ischemic stroke patients. This was not
observed in the permanent model perhaps due to the timing of the second iSTAT
collection, where animals may not have had an opportunity to compensate yet; these are
issues that need to be addressed in future studies.
The transient model had better survival rate than the permanent model. The
permanent model shows animal deaths occurred at various time points post-MCAO with
the majority occurring at 24 hours. The 24-hour time point is critical in human ischemic
stroke patients because this is the period when patients experience edema, herniation, and
hemorrhagic conversion resulting in increased mortality [34] We did not find this in the
transient model, which verifies the importance of reperfusion in ischemic stroke and
survival outcomes.
Conclusion
In this study, we demonstrated early significant changes in blood gases and
electrolyte concentrations after induction of a middle cerebral artery occlusion stroke.
This study shows that blood chemistry in the systemic circulation responds rapidly to the
ischemic event in the brain. Other studies examined one stroke model and one blood gas
parameter or electrolyte concentration, while we analyzed two separate MCAO models in
rats and the whole blood gas and electrolyte panel. Previous researchers have shown
variability in their results, however, our study shows the initial changes in pH and ionized
calcium are predictors of infarct volume in the permanent MCAO model. Our future
studies will examine aged male and female rats to address whether age and sex affects
this issue. Eventually we are planning to expand our blood gas studies to humans to
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determine if these results translate to human stroke patients, which would allow early
prediction of the stroke outcome.
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Table 2.1: Permanent Model
Venous blood paired samples T-Test in pre- and post- MCAO in young Sprague Dawley
male rats.
Permanent-MCAO
Parameters

n

Pre-MCAO
Mean ± SD

pH

14

7.249 ± 0.071

7.217 ± 0.075

0.033 ± 0.052

0.035

pCO2
(mmHg)

14

68.660 ± 9.397

75.890 ±
14.190

-6.229 ± 9.944

0.036

pO2 (mmHg)

14

105.929 ±
18.269

107.357 ±
21.685

-1.429 ± 18.711

0.780

BEecf
(mmol/L)

14

4.360± 1.008

3.070 ± 1.328

1.286 ± 1.069

0.001

HCO3(mmol/L)

14

31.380 ± 1.196

31.550 ± 2.008

-0.171 ± 1.082

0.564

Na (mmol/L)

14

133.570 ±
1.222

131.930 ±
1.439

1.643 ± 1.216

<0.001

K+ (mmol/L)

14

4.450 ± 0.231

4.711 ± 0.408

-0.261± 0.296

0.006

iCa2+
(mmol/L)

14

1.091 ± 0.138

1.190 ± 0.087

-0.099 ± 0.168

0.045

Glu (mg/dL)

14

290.290 ±
31.067

368.790±
58.380

-78.500 ±
47.383

<0.001

Hct (% PCV)

14

40.214 ± 1.424

40.429 ± 1.651

-0.214 ± 0.893

0.385

Hbg (g/dL)

14

13.679 ± 0.474

13.743 ± 0.543

-0.064 ± 0.295

0.430

+

Post-MCAO
Mean ± SD

D
Mean ± SD

P-value

Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters:
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (%
PCV); and Hbg: hemoglobin (g/dL).
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Table 2.2: Permanent Model
Multiple regression was performed to determine the correlations of venous blood gas and
electrolyte changes to infarct volume. As changes in pH and ionized calcium decrease,
infarct volume increases. These variables explained » 76% of the total variance in the
model as predictors of infarct volume in the permanent model.
Variable

B

SE B

β

p value

DpH

-86.155

21.050

-0.640

0.003

DiCa2+

-99.878

22.994

-0.679

0.002

R2 = .0806, adjusted R2 = 0.757, df = 2, F = 16.582, Durbin-Watson = 1.730
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Table 2.3: Transient Model Venous blood paired samples T-Test in pre- and post- MCAO
in young Sprague Dawley male rats.
Transient-MCAO
Parameters

n

Pre-MCAO
Mean ± SD

pH

12

7.263 ± 0.060

7.106 ± 0.143

0.157 ± 0.152

0.004

pCO2
(mmHg)

9

71.490 ±
14.155

93.530 ± 26.149

-22.044 ±
23.760

0.024

149.833 ±
42.734

-10.833 ±
41.772

0.388

Post-MCAO
Mean ± SD

D
Mean ± SD

P-value

pO2 (mmHg)

12

139.000 ±
26.823

BEecf
(mmol/L)

9

4.440 ± 1.810

4.110 ± 1.537

0.333 ± 1.118

0.397

HCO3(mmol/L)

9

31.310 ± 1.745

32.270 ± 2.502

-0.956 ± 1.731

0.136

Na+ (mmol/L)

12

133.83 ± 1.030

131.830 ± 1.749

2.000 ± 1.758

0.002

K+ (mmol/L)

12

4.342 ± 0.144

4.933 ± 0.485

-0.592 ± 0.414

<0.001

iCa2+
(mmol/L)

12

1.104 ± 0.151

1.222 ± 0.114

-0.118 ± 0.141

0.015

Glu (mg/dL)

12

305.330 ±
27.003

372.080 ±
114.099

-66.750 ±
103.660

0.047

Hct (% PCV)

12

39.000 ± 1.595

41.750 ± 2.137

-2.750 ± 1.138

<0.001

Hbg (g/dL)

12

13.250 ± 0.525

14.200 ± 0.727

-0.950 ± 0.397

<0.001

Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters:
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (%
PCV); and Hbg: hemoglobin (g/dL).
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Figure 2.1 Permanent-MCAO Timeline.

Figure 2.2 Transient-MCAO Timeline.
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Figure 2.3 Mortality data expressed using the Kaplan-Meier curve and analysis using the
Mantel-Haenszel log-rank test revealed significant difference in survival between
permanent and transients (p = 0.045). The numbers in parentheses represent the mortality
of rats at 24 hours and 48 hours. The surviving rats in the permanent model were n=11.
The surviving rats in the transient model were n=17.
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Figure 2.4 Representative permanent-MCAO infarct volume image. Fluoro-Jade staining
was performed on cryosections from rat brains to identify the damaged neurons 72 hours
post-MCAO. The range for permanent-MCAO infarct volumes were 24.40 – 90.79%.
Scale bars =150µm.

Figure 2.5 Representative transient-MCAO infarct volume image. Fluoro-Jade staining
was performed on cryosections from rat brains to identify the damaged neurons 72 hours
post-MCAO. The transient-MCAO infarct volumes ranged from 12.07 – 33.34%. Scale
bars =150µm.
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Figure 2.6: Permanent Model
P-P plot of residuals for change in pH and iCa2+ predictors of infarct volume.

Copyright © Sarah R. Martha 2019
28

CHAPTER 3. EARLY ACID/BASE AND ELECTROLYTE CHANGES IN PERMANENT MIDDLE
CEREBRAL ARTERY OCCLUSION: AGED MALE AND FEMALE RATS
Abstract
Background: Early changes in acid/base and electrolyte concentrations could provide
insights into the development of neuropathology at the onset of stroke. We evaluated
associations between acid/base and electrolyte concentrations, and outcomes in
permanent middle cerebral artery occlusion (pMCAO) model.
Methods: 18-month old male and female Sprague-Dawley rats underwent pMCAO. Pre-,
post- (7 minutes after occlusion), and at 72 hours of pMCAO venous blood samples
provided pH, carbon dioxide, oxygen, glucose, hematocrit, hemoglobin, and electrolyte
values of ionized calcium, potassium and sodium. Multiple linear regression determined
predictors of infarct and edema volumes from these values, Kaplan-Meier curve analyzed
morality between males and females at 72 hours, and a Cox regression model was used to
determine predictors for mortality.
Results: Analysis indicated significant differences in acid/base balance and electrolyte
levels in aged rats not dependent on sex between the three time points in the pMCAO
model. Changes in pH (from pre- to post and post- to 72 hours) and changes in sodium
and ionized calcium (from post- to 72 hours) were predictors of infarct volume and
edema volume, respectively. Cox Regression revealed there is a 3.25 times increased risk
for mortality based on changes in bicarbonate (pre- to post-MCAO).
Conclusions: These early venous blood changes in acid/base balance and electrolytes can
be used to predict stroke outcomes in our rat model of stroke. This study provides
potential biomarkers to be examined in the human condition that could provide profound
prognostic tools for stroke patients.
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Introduction
Stroke remains the leading cause of death and disability worldwide [1]. Edema
and electrolyte imbalance contribute to brain swelling, dysfunction, and death. Currently,
there are no early serum tests to predict risk of death from stroke-induced edema. While
MRI will show large infarcts early, it is no longer typically used in the emergent
presentation due to delaying urgent treatment. Therefore, identifying an easily obtainable
clinical marker to predict cerebral edema and death would be a major advancement in
stroke care. Many strokes are emergent large vessel occlusion (ELVO), in which there is
an acute occlusion of one of the vessels of the Circle of Willis. Accounting for 20-40% of
ischemic strokes, it is the most disabling form [2]. The permanent MCAO model best
represents the natural history of emergent large vessel occlusion (ELVO) stroke that is
untreated with thrombolytic therapy or mechanical thrombectomy [3]. Most patients with
ELVO currently do not receive either of these treatments, which results in a high
mortality rates or severe disabilities [4, 5].
Blockage of the large vessel artery reduces cerebral blood flow (CBF) below
functional levels depriving neurons of oxygenated glucose and blood. The penumbra, the
brain area adjacent to the infarction, is at risk of infarction if reperfusion does not occur
[6]. Oxygen (O2) and glucose are reduced in the blood downstream of the occlusion. A
deprivation in O2 and glucose contribute to the failure of adenosine triphosphate (ATP)
production and cerebral ischemia occurs when O2 supply fails to meet metabolic demand
[7]. Cells are forced into anaerobic glycolysis which leads to lactic acid accumulation,
which lowers the pH [8, 9]. Carbon dioxide (CO2) builds up and accumulates in
extracellular and intracellular spaces leading to decrease in pH [10]. The acidic pH
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impacts electrolyte concentrations such as sodium (Na+), calcium (Ca2+) and potassium
(K+) which regulate cellular structure and function [7]. Increased concentration of
intracellular Na+ causes cytotoxic edema. Additionally, the disruption of the Na+/Ca2+
pump results in an increased concentration of intracellular Ca2+ which initiates apoptosis,
causes mitochondrial dysfunction, and generates free radicals and reactive oxygen
species (ROS) [11]. These acid/base and electrolyte changes are associated with the
severity of the stroke [12], a greater understanding of the blood gas parameters allows us
further insight into how these factors influence stroke outcomes.
Previously, we have reported a change in blood gases and electrolytes within a
few minutes of focal ischemia in young male rats and these changes predict infarct
volume [12]. This study uses aged male and female rodents that are better aged-matched
to the typical age of the human stroke patient. Therefore, we aimed to examine venous
blood gas values in male and female aged rats at three time points: (1) pre-permanent
middle cerebral artery occlusion (pMCAO), (2) post-pMCAO, and (3) at 72 hours before
euthanization to determine whether venous blood gas values predict infarct volume,
edema volume, and/or mortality in pMCAO. This study identifies early changes in blood
gases/electrolytes that predict stroke outcomes in an experimental rodent model of stroke.
Materials and Methods
Ethics Approval and Animals
Aged male and female rats (18-month old Sprague-Dawley rats (ENVIGO,
Indianapolis, IN) were used for all procedures. The aged female rats on average weighed
between 245 and 425 grams, and aged male rats approximately weighed between 505 to
705 grams. The study was conducted in accordance with the National Institutes of Health
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(NIH) Guide for the Care and Use of Laboratory Animals and study protocols were
approved by University of Kentucky’s (UK) Institutional Animal Care and Use
Committee (IACUC). Animals were housed in a climate controlled room on a 12-hour
light and dark cycle (0700 - 1900) with access to food and water. Per Division of
Laboratory Animal Resources (DLAR) cage requirements at UK’s vivarium facility, the
animals can be paired in one cage if the animal weight is under 650 grams. We typically
house two animals (males or females) per cage upon arrival to DLAR. Once the rats are
over 650 grams, they are then split into a separate cage by themselves. Animals were
administered vehicle of sterile filtered phosphate buffered saline (PBS) of pH 7.4, at 6,
24, 48, and 72 hours after permanent middle cerebral occlusion (pMCAO). The rats that
survived to 72 hours (n = 16) underwent Magnetic Resonance Imaging (MRI) for
Diffusion Tensor Imaging (DTI) images and T2 weighted images to measure infarct and
edema volumes and then euthanized.
Permanent Middle Cerebral Artery Occlusion
During the pMCAO procedure, as previously described [13], animals were placed
in an induction chamber and anesthetized with 5% isofluorane/oxygen. During the
procedure, a constant flow of 3% isofluorane in 100% oxygen at a rate of 1 L/min was
maintained. A midline vertical neck incision occurred to collect an internal jugular blood
draw. Glass rods were used to separate the large muscle pad and the sternocleidomastoid
muscle (SCM). Retractors were placed to pull musculature of the SCM and skin tightly
away from the targeted area. Dissection of the omohyoid muscle, fat, and connective
tissues were made to isolate and expose the right common carotid artery from the vagus
nerve. Blunt dissection with glass rods occurred around the internal carotid artery (ICA)
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with removal of lymph nodes and fat surrounding the internal/external cerebral artery
(ICA/ECA) bifurcation to expose the pterygopalatine/middle cerebral artery (MCA)
bifurcation. The first clamp was placed on the ICA prior to the pterygopalatine/MCA
bifurcation, while the second clamp was placed on the common carotid artery (CCA).
The placement of the second clamp further in the posterior direction allows more room
for manipulation during the embolus insertion. The ECA was isolated, and used to access
the arterial system. A 40mm nylon monofilament was fed distally into the ECA and
advanced through to the ICA at approximately 25mm until it reached the ICA clamp. The
monofilament was loosely sutured in place, the first clamp was removed, and the
embolus was advanced then sutured in place to obtain permanent occlusion of the middle
cerebral artery (MCA), M1 segment. The second clamp was removed with careful
observation of minimal blood, then the removal of the retractors. Before the neck incision
closure, a post-MCAO blood draw occurred from the internal jugular vein.
Post-Surgical Fluid Management and Pain Control
Immediately post-operatively the animals received 2ml of sterile saline (0.9%)
subcutaneous. An additional 1ml of saline was given if extra blood loss occurred during
surgery. The animals were injected with sterile filtered PBS pH 7.4 at 6, 24, 48, and 72
hours post-MCAO. The animals were weighed every morning post-MCAO to determine
dehydration. Hydration status was checked by pinching up or “tenting” the skin over the
nape of the neck. The skin should immediately relax into its normal position. If the skin
remains tented longer than normal, the rat was deemed dehydrated and saline was given.
Per DLAR guidelines, rats can receive up to 10ml at a time and no more than 2ml at any
one location per 6 hours. If warranted, additional saline (1-2ml) will be given in addition
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to 6, 24, 48, and 72 hours. Also, we added an additional water bottle in each cage to
allow more availability to free water and moist food to encourage feeding and additional
water intake.
Post-surgical pain control was managed with carprofen, which is based on weight
of the animal. Animal weights are taken prior to surgery (pMCAO) and daily until
animals are euthanized at 72 hours (post MRI). The animals received a dosage of
carprofen 5mg/kg prior to surgery and every 24 hours for three days post-pMCAO until
72 hours when they were euthanized (post MRI).
Venous Blood Gas Collection
Blood gas samples were collected and analyzed pre- and post-MCAO, and prior
to euthanization at 72 hours. The venous blood sample was analyzed using iSTAT
Portable Clinical Analyzer (Abbott Laboratories, Abbott Park, IL) for pH, carbon dioxide
(pCO2), oxygen (pO2), bicarbonate (HCO3-), base excess of extracellular fluid (Beecf),
glucose, hematocrit, hemoglobin, and serum electrolytes, including ionized calcium
(iCa2+), potassium (K+), and sodium (Na+). Individual readings errors and these errors
were excluded from statistical tests. An internal jugular line was inserted, prior to MCAO
monofilament placement and an approximately 100µl of venous blood sample was
collected (representing the pre-MCAO sample, Figure 3.1). The venous circulation drains
into the confluence of the sinuses and then splits into right and left internal jugular veins
before recirculation through the heart [14]. Venous blood samples were collected from
the affected MCAO side of the animal. However, in certain cases venous blood samples
were collected from the contralateral side (unaffected MCAO side). The pre-pMCAO
blood sample takes approximately 30 minutes to obtain given the details of the procedure
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and anesthesia induction (represented by the shaded box for the variable time points,
Figure 3.1). Post-MCAO (approximately taken within seven minutes of occlusion), rats
remained anesthetized on the operating table and venous blood sample was again
collected (representing the post-MCAO sample). The third venous blood sample was
collected from the right atrium (Figure 3.1) in animals that survived to 72 hours.
Magnetic Resonance Imaging
MRI images were acquired on a 7T Bruker Clinscan horizontal bore system (7.0T,
30cm, 300Hz) equipped with a triple-axis gradient system (630 mT/m and 6300 T/m/s)
with a closed cycle. Diffusion Tensor Imaging (DTI) images were acquired coronally
with a fat saturated, double refocused echo planar sequence: 0.297 x 0.297 x 0.7 mm3,
TR/TE 2200/34, 128 x 128 matrix, 3 av, 12 slices, four b=0 volumes, 256 directions with
b=800, in 28:23 minutes (Figure 3.2.A). T2 weighted images were acquired coronally
with a fat saturated, turbo spin echo sequence: 0.125 x 0.125 x 0.4 mm3 resolution,
TR/TE 6000/27, 192 x 192 matrix, 44 slices, is 9:03 (Figure 3.2.C).
Male rats were anesthetized with an average of 2.25% isoflurane in oxygen, while
female rats were anesthetized with an average of 1.75% isoflurane in oxygen using an
MRI compatible CWE Inc. equipment (Ardmore, PA). They were held in place on a
Bruker scanning bed with a tooth bar, ear bars, and tape. Body temperature, heart rate,
and respiratory rates were continuously monitored throughout the MRI scans (SA
Instruments, Inc., Stony Brook, NY). The animal’s body temperature were maintained at
37°C with a water heating system built into the scanning bed. The scanning procedure
took approximately 40 minutes per animal.
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MRI Processing for Infarct Volume and Edema Volume
The DTI and T2 MR images were analyzed by a blinded neuroradiologist who
identified infarct volume and edema volume. These volumes were counted and the
number referenced to the number of images counted to provide a per section count. The
volume of brain parenchyma demonstrating restricted diffusion (infarct volume) visibly
affected were calculated by manual segmentation using ITK-SNAP software
(www.itksnap.org, version 3.6, Figure 3.2.B) [15]. The volume of brain parenchyma
visibly affected by cerebral edema (edema volume) were calculated in a similar fashion
(Figure 3.2.D). The data are given as absolute volume in cubic millimeters. The
calculation was based on all slices from each MR sequence.
Statistical Analysis
Data analysis began with a descriptive examination of all variables, including
frequency distribution, means, and standard deviations. The power analysis was
completed using G*Power software [16, 17]. Given a desired power of 0.8 and a
significance level for between-group comparisons set at p < 0.05, the required sample
size was calculated to be 14 animals (i.e., n = 7 per group). All variables in the study
were transformed to meet assumptions of normality. The transformation procedures
began with Shapiro-Wilks and for measures with p < 0.05, natural log with a constant of
10 added to measure. Data from the aged male and female rats were analyzed using
SPSS, version 24 software (IBM, Armonk, NY).
A repeated-measures analysis of variance (ANOVA) was used to examine
between-group differences of blood gas parameters of the sexes at three time points, preMCAO, post-MCAO, and at 72 hours-MCAO. Paired samples t-test were used to
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compare venous blood gas mean values between pre- and post-MCAO for the animals
that died prior to 72 hours, in addition to an independent t-test to compare venous blood
gas mean values between pre-MCAO animals that survived versus died prior to 72 hours.
A multiple linear regression with backward variable entry was performed with magnitude
of change data from aged male and female rats to determine whether venous acid/base
and electrolyte changes predicted infarct volume and/or edema volume. The variables
were entered into the regression model in one step. The adjusted R2 was used to
determine the variance explained in infarct volume and/or edema by each variable. An
assessment of multicollinearity was performed by inspecting correlation coefficients and
tolerance/variance inflation factor values. Inspecting the coefficients table and if
tolerance values are less than 0.10 or VIF is above 10, collinearity is present and was not
found in final model. The P-to-P plot was used to assess the changes in pH, iCa2+, and
Na+ data sets for normal distribution. A Kaplan-Meier curve using Mantel-Haenszel logrank test analysis was performed to compare survival curves between aged male and
female rats. A Cox regression curve was used to assess the relationship of event-free
survival in aged male and female rats using predictors of acid/base and electrolyte
concentration parameters. A p-value of 0.05 was set a priori to determine statistical
significance.
Sample Size
The total sample size from the permanent MCAO model were 31. These animals
are furthered categorized into those that survived to 72 hours (n = 16; males = 7 and
females = 9), and those that died prior to 72 hours (n = 15; males = 8 and females = 7).
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Results
Acid/Base and Electrolyte Values for Survival
Venous Blood Gas Differences Between Aged Male and Female Rats
A repeated-measures analysis of variance (ANOVA) was used to examine
between-group differences of blood gas parameters of the sexes at three time points, prepMCAO, post-MCAO, and at 72 hours-MCAO (Table 3.1). Mauchly’s test indicated that
the assumption of sphericity had been violated for each blood gas parameter therefore
degrees of freedom were corrected with Greenhouse-Geisser estimates of sphericity
(Table 3.2). There was not a significant interaction of time by group effect between the
three time points of blood gas parameters and sex (Table 3.3).
Acid/Base and Electrolyte Values for Death
Because there were no baseline differences between males and females rats that
died prior to 72 hours their data were collapsed into a single group. There were
significant differences in blood gas values seen from pre- to post-MCAO in animals that
died prior to 72 hours (n = 15, Table 3.4). pH (p = 0.026) and Na+ (0.039) decreased from
pre- to post-MCAO, while pCO2 (p = 0.015), HCO3- (p = 0.001) and glucose (p = 0.014)
increased. There were no significant differences seen in baseline (pre-MCAO) values
from those animals that survived and those that died prior to 72 hours (Supplemental
Table 3.1).
Predictors of Infarct Volume and Edema Volume
Blood gas and electrolyte changes from male and female rats were combined for
multiple linear regression analyses. Multiple regression analysis (n = 15) showed that the
changes in pH from pre- to post-MCAO and in pH from post to 72 hours-MCAO were
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predictors of infarct volume (F (2,14) = 14.77, p = 0.030). These variables explained 81%
of the total variance in the model (Table 3.5).
Multiple regression analysis (n = 16) revealed that the changes in iCa2+ from post
to 72 hours-MCAO and Na+ post to 72 hours-MCAO were predictors of edema volume
(F (2,15) = 12.32, p = 0.015). These variables explained 75% of the total variance in the
model (Table 3.6). The mean infarct size is 203.64 ± 61.41, while the mean edema
volume is 124.04 ± 41.39. There was no significant difference (p = 0.524) in infarct size
between aged male (n = 6) and female rats (n = 9) or in edema volume (p = 0.730)
between aged male (n = 7) and female rats (n = 9).
Relationship Between MCAO and Mortality
A Kaplan-Meier curve with Mantel-Haenszel log-rank test was used to analyze
event-free survival between aged male and female rats. There was no difference between
male and female rats based on mortality (p = 0.321, data not shown). In the Cox
regression, there a 3.25 times (or 325%) greater risk for mortality for rats within the -2.00
to -7.00 cut-off range for HCO3- (pre- to post-MCAO), after controlling for change in Na+
and sex (p = 0.025) (Figure 3.3).
Discussion
Previously, we have reported that changes in venous blood pH and ionized
calcium (pre- to post-MCAO) predicted infarct volume in young male rats [12]. We now
extend our findings to aged male and female rats after pMCAO. The venous blood gas
profile after pMCAO significantly differed between the young and aged. Our aged rats
(18 months equivalent to approximately 55-65 years old in humans [18]) are a better age
match for human stroke patients. A major issue in stroke research is the lack of
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translating findings from the rodent to the human patient. The almost uniform use of
young male rats in stroke research is one of the contributing factors for this problem. Our
expectations were that data acquired from aged rats should be more translatable to human
stroke. While we did not find any differences in the venous blood between the sexes, we
use both sexes to better reflect the human population. Gender-specific responses to stroke
therapies are well-documented, and most recently exemplified in the experience with the
clinical trial showing that uric acid is effective with females but not male stroke patients
[19].
These changes in pH taken together are predictors that affect infarct volume. The
importance of this finding occurring in the post-MCAO to 72-hour mark is important for
translational studies, because this period would be the most applicable as a prognostic
tool for the human patient. The pH is tightly regulated in the blood and other tissues to
maintain homeostasis. The accumulation of lactic acid and CO2 in ischemic brain disrupts
the normal pH balance [9]. Our study showed significant changes of pH as a predictor of
infarct volume, but interestingly, a predictor that varied depending on the time point pH
was measured. At the first timepoint (from pre- to post- MCAO), our results demonstrate
that as changes in pH increased, infarct volume increased. At the second timepoint (from
post-MCAO to 72 hours), as changes in pH increased, infarct volume decreased.
Carbon dioxide and water are catalyzed by carbonic anhydrase, which results in
the generation of bicarbonate and H+ [20]. The H+ proton facilitates transport of Na+
across membranes. Other electrolytes and water follow the transport of Na+ during
ischemia, causing malignant cerebral edema. Bicarbonate production is low in blood
under alkaline conditions, and is high in acidic conditions found in ischemia. Its purpose
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is to regulate pH homeostasis, and to facilitate anion/water transport. In heart ischemia
reperfusion, the presence of bicarbonate causes increased oxidative damage [21], which
leads to increased inflammation. While ELVO causes significant injury to the affected
brain, the associated malignant edema injures surrounding otherwise unaffected brain,
caused herniation and death [22]. These early changes in bicarbonate predict mortality of
aged rats of both sexes and provides a potential biomarker to be explored in human stroke
patients.
We have also identified predictors related to edema, which can be a lethal
consequence of cerebral infarction. Changes in ionized calcium and sodium post-MCAO
to 72 hours predicted for edema volume. We found an inverse relationship, as changes in
ionized calcium and sodium (post-MCAO to 72 hours) to edema volume, as ionized
calcium and sodium increased, edema volume decreased. To our knowledge neither
ionized calcium, nor sodium were previously reported to affect edema volume as a stroke
outcome. They are, however, discussed in connection with infarct volume, patient
functional outcomes, and mortality. In human stroke patients, severe clinical presentation
was seen after stroke onset, as was worsening of functional outcomes, and the potential
for hemorrhagic conversion post-thrombectomy; these were associated with lower total
serum calcium concentrations in peripheral venous blood [23-25]. Conversely, better
functional outcomes and decreased infarcts were associated with higher venous total
serum calcium levels [26-28]. These findings link positive stroke outcomes to increased
serum calcium levels. Yet, also seen in human stroke patients were inconsistent results of
associations between serum Na+ levels and stroke severity. Patients with increased stroke
severity and mortality exhibited associations with hyponatremia or lower Na+ levels [29,
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30]. While others found associations between increase stroke incidence and neurological
worsening with higher venous serum Na+ concentrations [31-33]. However, these studies
relied on univariate analyses so multivariate analyses appear to add more understanding
of the associations of biomarkers with functional or neurological outcomes.
The Cox regression showed changes in bicarbonate levels were also an important
predictor for increased risk for mortality. Bicarbonate is important for pH, electrolyte,
and water balance, which is disturbed during ischemic stroke. Bicarbonate levels changed
rapidly after inserting the embolus into the internal carotid artery to block the middle
cerebral artery, approximately within 7 minutes. Our data show that the physiological
buffering response of the rats is impaired post-pMCAO; they are unable to adjust their
blood homeostasis, leading to mortality. To our knowledge, this is the earliest change in
bicarbonate measurement after experimental stroke to be reported. Moreover, this finding
shows that there are two rat subpopulations. One is able to regulate bicarbonate and
survive and other unregulated bicarbonate levels increased probability of death by 328%.
If translated to humans, this would suggest that early bicarbonate levels could inform
treatment for the patient after stroke.
There is, however, some distinction between the pMCAO model in young and
aged rats in acid/base balance and electrolyte concentrations as predictors of infarct
volume. In our previous paper, we discovered as changes in pH and ionized calcium
(from pre- to post-MCAO) increased, infarct volume decreased in young male rats [12].
This finding is inverse from results related to aged rats, which show that as changes in pH
(from pre- to post-MCAO) increased, infarct volume increased. We also previously found
that as changes in ionized calcium (from pre- to post- MCAO) increased, infarct volume
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decreased. These changes were not found in aged rats, rather there was an association
with changes in ionized calcium at a different time point (post-MCAO to 72 hours) with
an increase in edema volume. The differences between young and aged rats demonstrate
that some blood gas and electrolyte parameters are age dependent, while others are not.
Translation of findings from rodent to human has been problematic in stroke research
with the almost exclusive use of young male rats. As demonstrated by this study,
differences in the response to stroke arise between young and aged rats. These aged rats
are a closer age match to human stroke patients and could be a better model for
translation to humans.
The physiological significant of this study is that the response to ischemia is rapid
within minutes. Water movement is associated with transport of electrolytes, primarily
with sodium. Our data indicate that if the brain is able to maintain the electrolytes,
ionized calcium and sodium, within the blood then edema is reduced. This study suggests
infarct volume and death may occur if buffering in the blood is unable to maintain blood
homeostasis. The maintenance of pH is essential as acidosis will result in neural cell
death to expand the infarct volume [15, 34, 35]. Bicarbonate, as discussed above, plays a
critical role in maintaining blood homeostasis and the dysregulation of bicarbonate. In
fact, serum bicarbonate is associated with heart failure and mortality [36].
Conclusion
In conclusion, we showed shows that blood chemistry in the systemic circulation
responds rapidly to an ischemic event in the brain. Of the three time points used, the postMCAO and 72-hour time points would be most applicable to the human stroke patients
since they receive treatment hours after having a stroke. Finally, bicarbonate stands out as
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the most promising indicator from our study, providing us with a predictive range for
mortality but must be examined in the context of the human patient. Overall, these studies
will provide acid/base and electrolyte concentrations as potential predictive biomarkers
for stroke outcomes. These studies need be verified in human patients an at appropriate
time points in patient care. However, the use of multivariate analyses appears to be more
appropriate approach in determining predictive biomarkers.
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Table 3.1: Venous blood gas analyses at pre-, post-, and 72 hours pMCAO in aged male
and female Sprague Dawley rats.
All Rats
Male
Female
PParameters
value
Mean ± SD
Mean ± SD
Mean ± SD
pH
pre-MCAO
0.125
7.30 ± 0.04
7.32 ± 0.04
7.29 ± 0.03
post-MCAO
7.23 ± 0.07
7.27 ± 0.04
7.20 ± 0.06
72 hours
7.24 ± 0.04
7.26 ± 0.03
7.23 ± 0.04
pCO2 (mmHg)
pre-MCAO
60.11 ± 6.29
58.38 ± 6.58
61.27 ± 7.23 0.213
post-MCAO
77.08 ± 6.77
71.05 ± 6.94
81.10 ± 6.06
72 hours
74.68 ± 7.62
73.83 ± 7.66
75.24 ± 7.58
pO2 (mmHg)
pre-MCAO
125.33 ± 13.87 127.00 ± 11.24 123.22 ± 15.56 0.409
post-MCAO
103.33 ± 14.72 102.50 ± 16.67 103.89 ± 12.21
72 hours
9.93 ± 1.76
9.17 ± 1.48
10.44 ± 1.96
Beecf (mmol/L)
pre-MCAO
0.612
3.33 ± 0.49
4.50 ± 0.64
3.56 ± 0.35
post-MCAO
4.80 ± 0.27
5.33 ± 0.36
3.78 ± 0.20
72 hours
5.00 ± 0.62
6.83 ± 0.81
3.76 ± 0.45
HCO3- (mmol/L)
pre-MCAO
29.95 ± 1.59
30.35 ± 1.26
29.69 ± 1.83 0.317
post-MCAO
31.65 ± 2.03
32.27 ± 1.43
31.23 ± 2.34
72 hours
32.47 ± 2.84
34.18 ± 2.88
31.33 ± 2.80
Na+ (mmol/L)
pre-MCAO
137.60 ± 1.51
137.17 ± 1.72
137.89 ± 1.36 0.774
post-MCAO
136.00 ± 1.56
135.67 ± 1.37
137.22 ± 1.72
72 hours
144.20 ± 3.35
143.33 ± 3.23
144.78 ± 3.58
K+ (mmol/L)
pre-MCAO
0.871
3.73 ± 0.34
3.97 ± 0.21
3.57 ± 0.32
post-MCAO
3.87 ± 0.30
4.03 ± 0.31
3.77 ± 0.27
72 hours
4.59 ± 0.48
4.77 ± 0.66
4.45 ± 0.30
iCa2+ (mg/dL)
pre-MCAO
0.673
1.01 ± 0.16
1.01 ± 0.11
1.02 ± 0.19
post-MCAO
1.03 ± 0.13
1.07 ± 0.15
1.01 ± 0.12
72 hours
1.22 ± 0.13
1.27 ± 0.10
1.18 ± 0.14
Glu (mg/dL)
pre-MCAO
223.67 ± 22.67 237.67 ± 19.52 214.33 ± 24.81 0.712
post-MCAO
346.87 ± 36.26 357.67 ± 33.87 339.67 ± 38.36
72 hours
156.67 ± 16.19 158.50 ± 18.63 155.44 ± 14.89
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Table 3.1 (continued).
Hct (% PCV)
pre-MCAO
post-MCAO
72 hours
Hbg (g/dL)
pre-MCAO
post-MCAO
72 hours

40.13 ± 2.13
41.23 ± 2.65
35.27 ± 1.20

42.33 ± 2.07
42.67 ± 2.80
37.17 ± 1.31

38.67 ± 2.24
39.45 ± 2.42
33.44 ± 1.13

0.268

13.65 ± 0.76
14.40 ± 0.71
13.14 ± 0.77 0.158
13.65 ± 0.68
14.53 ± 0.57
13.07 ± 0.72
11.99 ± 1.48
13.63 ± 1.20
10.90 ± 1.63
Data are presented as mean ± standard deviations. Total sample size N = 16; n = 7 male
rats, n = 9 female rats. P values represent the interaction of 3 time points x gender. Blood
gas and electrolyte parameters: pCO2: Partial pressure of carbon dioxide (mmHg); pO2:
partial pressure of oxygen (mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit
(mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation (%); Na+: sodium
(mmol/L); K+: potassium (mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose
(mg/dL); Hct: hematocrit (% PCV); and Hbg: hemoglobin (g/dL).
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Table 3.2: Mauchly’s test indicated that the assumption of sphericity had been violated
for each blood gas parameter therefore degrees of freedom were corrected with
Greenhouse-Geisser estimates of sphericity.
Variable

Approximate
Chi-Square

df

Greenhouse-Geisser
Estimate of Sphericity

Significance

pH

22.26

2

e = 0.678

p <0.001

pCO2

23.49

2

e = 0.791

p <0.001

pO2

20.45

2

e = 0.550

p <0.001

HCO3-

15.61

2

e = 0.579

p <0.001

Beecf

17.75

2

e = 0.564

p <0.001

Na+

13.64

2

e = 0.596

p <0.001

K+

11.05

2

e = 0.517

p <0.001

iCa2+

12.26

2

e = 0.502

p <0.001

Glu

8.31

2

e = 0.667

p = 0.016

Hct

15.98

2

e = 0.569

p <0.001

Hbg

17.06

2

e = 0.572

p <0.001

Blood gas and electrolyte parameters: pCO2: Partial pressure of carbon dioxide
(mmHg); pO2: partial pressure of oxygen (mmHg); HCO3-: bicarbonate (mmol/L); BD:
base deficit (mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation (%); Na+:
sodium (mmol/L); K+: potassium (mmol/L); iCa2+: ionized calcium (mmol/L); Glu:
glucose (mg/dL); Hct: hematocrit (% PCV); and Hbg: hemoglobin (g/dL).
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Table 3.3: There was not a significant interaction effect between the three time points of
blood gas parameters and sex.
Variable

F

df

Significance

pH

2.27

2

p = 0.125

pCO2

1.64

2

p = 0.213

pO2

1.17

2

p =0.409

HCO3-

1.12

2

p = 0.317

Beecf

0.31

2

p = 0.612

Na+

0.12

2

p = 0.774

K+

0.14

2

p = 0.871

iCa2+

0.39

2

p = 0.673

Glu

0.22

2

p =0.712

Hct

1.75

2

p = 0.268

Hbg

1.39

2

p = 0.158

Blood gas and electrolyte parameters: pCO2: Partial pressure of carbon dioxide (mmHg);
pO2: partial pressure of oxygen (mmHg); HCO3-: bicarbonate (mmol/L); BD: base
deficit (mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation (%); Na+: sodium
(mmol/L); K+: potassium (mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose
(mg/dL); Hct: hematocrit (% PCV); and Hbg: hemoglobin (g/dL).
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Table 3.4: Pre- and post-MCAO acid/base and electrolyte values for animals that died
prior to 72 hours.
Pre-MCAO

Post-MCAO
Mean ± SD

P-value

Parameters

n

pH

15

7.31 ± 0.05

7.19 ± 0.12

0.026

pCO2 (mmHg)

15

58.54 ± 4.80

91.13 ± 6.09

0.015

pO2 (mmHg)

15

121.29 ± 14.41

119.57 ± 13.72

0.686

Beecf (mmol/L)

15

3.50 ± 0.52

3.52 ± 0.55

0.919

HCO3- (mmol/L)

15

29.50 ± 2.24

35.67 ± 2.36

0.001

Na+ (mmol/L)

15

137.19 ± 1.60

134.00 ± 1.67

0.039

K+ (mmol/L)

15

3.81 ± 0.47

4.11 ± 0.43

0.151

iCa2+ (mg/dL)

15

1.02 ± 0.11

1.04 ± 0.13

0.657

Glu (mg/dL)

15

259.86 ± 31.99

360.00 ± 34.04

0.014

Hct (% PCV)

15

41.84 ± 2.48

42.86 ± 3.19

0.522

Hbg (g/dL)

15

13.99 ± 0.83

13.90 ± 1.10

0.589

Mean ± SD

Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters:
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (%
PCV); and Hbg: hemoglobin (g/dL).
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Supplemental Table 3.1: Baseline acid/base and electrolyte values for combined
males and females groups.
Survived
N=16

Died Prior to 72
hours
N = 15

Pre-MCAO

n

Pre-MCAO
Mean ± SD

P-value

Parameters

n

pH

16

7.30 ± 0.04

15

7.31 ± 0.05

0.525

pCO2
(mmHg)

16

60.11 ± 6.29

15

58.54 ± 4.80

0.537

16 125.33 ± 13.87

15

121.29 ± 14.41

0.412

Beecf
(mmol/L)

16

3.33 ± 0.49

15

3.50 ± 0.52

0.673

HCO3(mmol/L)

16

29.95 ± 1.59

15

29.50 ± 2.24

0.883

Na+ (mmol/L) 16

137.60 ± 1.51

15

137.19 ± 1.60

0.792

16

3.73 ± 0.34

15

3.81 ± 0.47

0.463

iCa2+ (mg/dL) 16

1.01 ± 0.16

15

1.02 ± 0.11

0.633

pO2 (mmHg)

K+ (mmol/L)

Mean ± SD

Glu (mg/dL)

16 223.67 ± 22.67

15

259.86 ± 31.99

0.179

Hct (% PCV)

16

40.13 ± 2.13

15

41.84 ± 2.48

0.347

Hbg (g/dL)

16

13.65 ± 0.76

15

13.99 ± 0.83

0.266

Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters:
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (%
PCV); and Hbg: hemoglobin (g/dL).
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Table 3.5: Predictors of infarct volume in aged rats (n = 15)
Variable

β

P-value

DpH (pre- to post-MCAO)

0.667

0.031

DpH (post- to 72 hours-MCAO

-0.683

0.034

R2 = 0.862, adjusted R2 = 0.813, df = 2, F = 14.77, p = 0.030, Durbin-Watson = 1.35
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Table 3.6: Predictors of edema volume in aged rats (n = 16)
Variable

β

P-value

DNa+ (post- to 72 hours-MCAO)

-1.355

0.011

DiCa2+ (post- to 72 hours-MCAO)

-0.973

0.018

R2 = 0.813, adjusted R2 = 0.745, df = 2, F = 12.32, p = 0.015, Durbin-Watson = 2.13
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Figure 3.1 Permanent Timeline: The first venous blood sample collection (represented by
1st iSTAT) to MCAO takes approximately 30 minutes (represented by the shaded box).
The post-MCAO sample was taken approximately seven minutes after induction of the
MCAO (represented by 2nd iSTAT). The MRI scans and 3rd iSTAT collection were
obtained before euthanization at 72 hours.

Figure 3.2.A-D MRI Images of Infarct and Edema Volumes

3.2a: Representative permanent-MCAO Diffusion Tensor Imaging (DTI) image of infarct
volume. 3.2b: Representative permanent-MCAO T2-weighted image of edema volume.
3.2c: DTI imaging revealed the volume of brain parenchyma demonstrating restricted
diffusion of infarct volume visibly affected after pMCAO. Shading indicates the
calculation made by manual segmentation. 3.2d: T2 weighted imaging revealed the
volume of brain parenchyma demonstrating restricted diffusion of edema volume visibly
affected after pMCAO. Shading indicates the calculation made by manual segmentation.
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Figure 3.3: Cox Regression and Mortality (n = 31).

Copyright © Sarah R. Martha 2019
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CHAPTER 4. EVALUATION OF SEX DIFFERENCES IN ACID/BASE AND ELECTROLYTE
CONCENTRATIONS IN ACUTE LARGE VESSEL STROKE

Abstract
Introduction and Purpose: We have developed a protocol to collect and evaluate arterial
blood immediately distal and proximal from the removed intracranial thrombus during
mechanical thrombectomy. These samples provide a unique resource in evaluating acute
changes in acid/base and electrolyte concentrations at the time of ischemic stroke. The
purpose of this study was to compare acid/base and electrolytes obtained proximal and
distal to the occluded intracranial thrombi between male and female acute ischemic
stroke participants at the time of thrombectomy; and to determine whether arterial blood
gas values predict outcomes in male and female participants.
Methods: We analyzed the first 49 subjects (age = 67 ± 15.0, 21 males) in the BACTRAC
registry. We compared arterial blood gas of blood distal versus proximal to the thrombus
during thrombectomy which provided acid/base levels (pH, pCO2, pO2, BD, HCO3-) and
electrolyte values (iCa2+, K+, and Na+). Comparisons were evaluated by one-way
repeated measures ANOVA (p < 0.05. Moderated multiple regression with an interaction
term of sex determined predictors of infarct volume, edema volume, and infarct time.
Results: Our participants revealed compensated metabolic acidosis with an elevated
oxygen concentration in both blood samples. Analysis indicated several significant
differences in the proximal blood samples between sex (pH, pCO2, and K+). Bicarbonate
and base deficit were predictors of infarct time in only female participants.
Discussion and Conclusion: Acid/base and electrolyte response to ischemic conditions
differ between men and women and these early changes could be used to predict stroke
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outcomes in a sex-dependent manner. These findings provide a novel insight into the
pathology of large vessel stroke in humans, particularly in men and women.
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Introduction
Ischemic stroke is the leading cause of disability in the United States and affects
over 800,000 Americans per year [1]. Approximately 87% of strokes are ischemic,
resulting from an obstruction of blood flow to the brain [1]. When a cerebral thrombus
blocks an artery, tissue damage transpires within a few hours of ischemic stroke onset
due to neuronal cell death but with treatment the dying neurons in the penumbra may be
salvaged [2, 3]. Acute ischemic stroke triggers an ischemic cascade which causes injury
to cerebral tissue; this cascade may persist for many days post stroke. The
pathophysiological processes following ischemic stroke are complex, involving acidosis,
energy failure, increased intracellular calcium, excitotoxicity, activation of neuronal and
glial cells, free radical production, and disruption of the blood-brain barrier (BBB) [4, 5].
Because time is crucial, treatments have focused on removing the thrombus as quickly as
possible.
The current standard treatment of acute ischemic stroke focuses on recanalization
of the occluded intracranial vessel. Current therapies aim to dissolve or remove the
thrombus; this includes the use of tissue plasminogen activator (tPA) and mechanical
thrombectomy [6-8]. tPA is a serine enzyme that catalyzes the conversion of plasminogen
to plasmin, which is the primary mechanism for thrombolysis and mechanical
thrombectomy is a procedure to remove a thrombus and re-establish blood flow for
emergent large vessel occlusions (ELVO) [9, 10]. Unfortunately, patients must meet
specific criteria to receive either or both of these treatments, and the treatments must be
administered within the first few hours from stroke onset to achieve optimal efficacy for
better functional outcomes [9-13]. Rates of arterial recanalization are higher due to the
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use of tPA and mechanical thrombectomy, yet their effect on patient long-term functional
outcomes remains inconclusive [14-16]. It is also unclear whether outcomes after stroke
treatment for ELVO differ by sex.
A principal variable that may be affecting stroke outcomes is the biological sex of
the patient. Ischemic stroke is the fifth leading cause of death for men in the US, but third
leading cause of death for women, occuring in about 55,000 more women than men each
year [1]. Women age 45-65 years old are at a higher risk (20%) of having a recurring
stroke compared to their male counterparts (10%) [1]. Clinical studies have demonstrated
the existance of sex-specific effects of stroke therapies. In a failed clinical trial, uric acid
was found as an effective treatment in women, but not men [17]. This finding initially
went unnoticed and was detected only after the results were reanalyzed according to sex
differences [17]. As such, there is a need to further explore the relationship of sex
differences and stroke outcome by an evaluation of males and females
neurophysiological changes after stroke.
While mechanical thrombectomy and tPA have both become standards of care,
mechanical thrombectomy provides a rare opportunity to examine neurophysiological
changes occurring during stroke. In the setting of mechanical thrombectomy for emergent
large vessel occlusion (ELVO), we have developed a protocol to collect and evaluate
blood immediately distal and proximal from the removed intracranial thrombus [18]. We
can analyze these tissues to better understand their neurochemical properties and assist in
the development of adjunctive therapies to compliment current stroke treatments,
particularly whether those treatments need to be specially tailored to men or women.
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Our previous two studies reported changes in venous acid/base and electrolyte
concentrations within a few minutes of focal ischemia in young male rats, in addition to
aged male and female rats, and these changes predicted infarct and edema volumes and
mortality [19]. Our findings in animal models of stroke suggested that changes in early
blood chemistry might be used to predict stroke outcomes. Thus, the purpose of this study
was to evaluate the acid/base and electrolytes in distal and proximal blood to the
occluded intracranial thrombi between male and female acute ischemic stroke
participants at the time of thrombectomy; and to determine whether these acid base and
electrolyte values predict stroke outcomes (infarct and edema volume and/or infarct time)
dependent on sex.
Methods
Study Design
We developed the Blood and Clot Thrombectomy Registry and Collaboration
(BACTRAC) protocol: an Institiutional Review Board approved tissue banking strategy
for emergent large vessel occlusion (clinicaltrials.gov NCT03153683) [18]. The
BACTRAC study is a non-probability, convenience sample of participants (³ 18 year
olds) treated with mechanical thrombectomy for ELVO ischemic stroke at a large
academic comprehensive stroke center in Lexington, Kentucky between May 2017
through December 2018. Institiutional Review Board approval was obtained, and all
participants or legal authorized representative provided informed consent.
A sample size of 45 was determined by a power analysis calculation based on
planned analyses for independent t-tests, one-way repeated measures analysis of variance
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(RM-ANOVA), and moderated multiple regression. Independent t-tests were calculated
using a level of 0.05, and power of 0.80, and a medium effect size. RM-ANOVA were
calculated using a level of 0.05, and power of 0.80, and a large effect size. For moderated
multiple regression, sample size were calculated with a level of 0.05, power of 0.80, a
large effect size, and appropriate number of predictors.
Sample Population
Participants age 18 and over who were hospitalized with a diagnosis of an
ischemic stroke who underwent thrombectomy were screened for study eligibility.
Participants were candidates for inclusion if they meet criteria: a) signed and dated
informed consent (within 24 hours of thrombectomy completion time), b) adult males and
females of all races/ethnicities, c) acute ischemic stroke based on clinical and
radiographic evidence as determined by stroke neurology team, d) for intra-arterial
thrombectomy as determined by neurointerventional radiologist attending physican, e)
have an acute thromboembolus within an intracranial artery in a large cerebral artery (i.e
internal carotid, anterior cerebral, middle cerebral) or posterior circulation
(vertebral/basilar), f) participants with impaired capacity may be included, since the
ischemic stroke might be the cause of their incapacity, and g) to undergo endovascular
thrombectomy. Participants were excluded if a) they were pregnant or breastfeeding, b)
had disability from a prior stroke due to the inability to control for preexisting
neurological impairment, and c) were participating in other studies receiving treatment
that may alter their functional outcomes. The study adheres to IRB protocols.
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Data Collection
On admission to the study, demographic data were collected from the
participant’s medical record. Baseline medical history and comorbidity conditions,
concomittant medications, vital signs, National Institutes of Health Stroke Scale
(NIHSS), computerized tomography (CT) scan to verify large vessel occlusion stroke and
thrombectomy eligibility, and time of last known normal (LKN) symptoms (prior to
ischemic stroke) were identified.
Once a participant was determined by neurointerventional radiologist (NIR) for
thrombectomy they were then enrolled into the study. During the thrombectomy
procedure, the NIR obtained approximately 1ml of whole arterial blood from the
microcatheter distal to the cerebral thrombus, prior to thrombectomy and approximately
7ml of whole arterial peripheral blood from the internal carotid artery. This was a
coordinated effort between the on-call research staff, attending NIR, and procedural nurse
for the participant. From the distal and peripheral blood samples collected, 500 µL (0.5
ml) of peripheral blood and distal blood were sent to the hospital’s central laboratory for
blood gas (pH, partial pressure carbon dioxide, partial pressure oxygen, base deficit, and
bicarbonate) and electrolyte values (ionized calcium, potassium, and sodium) separately
through aliquots placed into standard hospital blood gas kits. The remaining blood was
initially processed and stored in -80 freezer for future analyses. Within 24 hours postthrombectomy, LKN to thrombectomy completion time (infarct time), thrombolysis in
cerebral infarction (TICI) score, magnetic resonance imaging (MRI) and/or computed
tomography (CT) scan was performed and radiographic endpoints were collected: infarct
and edema volumes, hemorrhagic grade, and CTA collateral score. A final NIHSS was
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performed at discharge. These data were entered into the study institution’s stroke
registry that is maintained using REDCap software.
Data Analysis
Descriptive statistics were used to characterize the participants by male and
female. Participant demographics and baseline characteristics were assessed with
independent t-tests for continous variables and Chi-square tests of associations based on
categorical (ordinal and binary) variables to assess for sex differences. Comparisons of
acid/base and electrolyte concentrations from distal to peripheral blood between the sexes
were evaluated by one-way repeated measures ANOVA. A moderated multiple
regression with interaction term of sex was used to determine predictors of stroke
outcomes (infarct and edema volumes, and/or infarct time). An interaction term was
created with acid/base and electrolyte variables x sex and were entered into the regression
model in two steps with backward entry. Dummy variable of sex was coded as male = 0,
female = 1. Age was entered into block 1 as a control variable, the functional outcome
variables (infarct volume, edema volume, and infarct time) were dependent variables,
while mean changes in acid/base parameters x sex were entered into block 2. The
adjusted R2 determined the variance explained in the functional outcomes by each
variable. Multicollinearity was assessed in each regression and P-to-P plot was used to
assess the changes in acid/base and electrolyte concentration data for normal distribution.
Data from ischemic stroke participants were analyzed using SPSS, version 24 software
(IBM, Armonk, NY). An alpha of 0.05 was used to determine statistical significance.
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Results
Sample Characteristics
Forty-nine participants were treated with mechanical thrombectomy during the
study period. Our participants were primarily female (57%), Caucasians (84%), and aged
67 ± 15 (Table 1). Sample participant characteristics and comparison based on gender are
presented in Table 1. There were similarities in BMI, smoking status, NIHSS on
admission and discharge, recanalization rate of TICI scores, infarct and edema volumes,
and hemorrhagic grade between the sexes. The majority of comorbidities were similar
between the sexes, however more females (42.9%) than males (9.5%) were diabetic (p =
0.004). More males (47.6%) than females (17.9%) displayed absent collaterals on
presentation, over 50% of an M2 territory (p = 0.027), while more females (57.1%) than
males (42.9%) presented with diminished collaterals, over 50% of M2 territory. The
mean infarct time based on symptom onset to thrombectomy completion time
demonstrated over a two hour difference between females (8 hours and 53 minutes)
compared to males (6 hours and 35 minutes; p = 0.081).
Arterial Blood Gas Differences Between Male and Female Participants
Results from the one-way repeated measures analysis of variance (RM-ANOVA)
of blood gas parameters of the sexes from distal and proximal arterial blood at the time of
thrombectomy are presented in Table 2. There were sex differences in pH (male 7.34 ±
0.04 vs female 7.39 ± 0.06, p = 0.046), partial pressure carbon dioxide (male 39.60 ±
4.22 vs female 36.40 ± 3.87, p = 0.002), and potassium (male 3.66 ± 0.42 vs female 3.31
± 0.46, p = 0.004) in proximal samples. The other measured blood gas and electrolyte
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concentrations did not show significant differences between the sexes. Mauchly’s test
indicated that the assumption of sphericity had been met since it is based on two levels
(distal and proximal). There were significant interaction effects between two of the distal
and proximal samples based on sex (partial pressure carbon dioxide: df = 1, F = 8.87, p =
0.005; and potassium: df = 1, F = 1.816, p = 0.009).
Predictors of Stroke Outcomes
To examine the possibility that sex was a moderator, an interaction term of sex
was created for acid/base and electrolyte concentrations. Moderated multiple regression
analyses (n = 49) were nonsignificant in the changes of acid/base and electrolyte
parameters to infarct volume and edema volume (p > 0.05) (Tables 4.3 and 4.4). An
additional moderated multiple regression analyses (n = 49) with interaction term of sex
demonstrated the changes in base deficit (BD) and bicarbonate (HCO3-) from distal to
proximal arterial blood samples were predictors of infarct time (F (4, 27) = 3.023, p =
0.042) after controlling for age. This indicates a positive coefficient between BD and
HCO3- together with the extent of infarct time, as changes in BD and HCO3- increased,
infarct time increased. These variables explained 12% of the total variance in the model,
as predictors of infarct time (Table 4.5).
Discussion
Overall, our results revealed there was relationship between base deficit,
bicarbonate, and infarct time, in women but not men. Women had increased infarct time
compared to men and on average and had a higher volume of collaterals on presentation
to the hospital (57.1% to 42.9%). Additionally, we expected to see acidosis and hypoxia
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in the distal blood due to the blockage of the artery from the cerebral thrombus. This
study shows that regardless of sex differences there was a compensated metabolic
acidosis with an elevated oxygen concentration in our ischemic stroke participants at the
time of thrombectomy.
We determined that as changes in base deficit and bicarbonate increased, infarct
time increased, but only in female participants. On average our female participants had a
two and half hour increase in time from their last known normal symptom to
thrombectomy completion time compared to male participants. We are unsure why
women’s treatment time varied from men’s treatment time, but we might speculate from
existing research that this is due to the different social experience of men and women.
Women experience pre-stroke social isolation and lack of support, which has been found
to contribute to poorer functional outcomes after stroke due to poor compliance,
depression, and stress compared to men [21]. Framingham Heart Study found women
more at risk for stroke incidence, lifetime risk of stroke, age at first stroke, post-stroke
disability, and institutionalization rates [22]. Therefore, a delay in treatment for women
could increase the damage from an ischemic stroke and decrease their chances of
receiving treatments, such as tPA. In an experimental model of stroke, we found venous
blood bicarbonate in aged rats to be a predictor for mortality with no sex differences [23].
However, a larger sample size is needed for the variability seen in the ischemic stroke
population to uncover associations, such as mortality or other poorer stroke outcomes,
especially if sex dependent.
Other sex differences were detected in proximal blood in pH, partial pressure
carbon dioxide (pCO2), and potassium (K+). These findings demonstrate differences in
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the early response in blood to stroke between men and women. A larger sample would
give us insights into whether these factors could be used as determinants of prognostic
factors for stroke outcomes which may differ between men and women.
To our knowledge, only one other report exists that evaluated distal and proximal
arterial blood samples adjacent to the cerebral thrombus, Flores et al. (2011) found
significant differences in partial pressure oxygen and oxygen saturation from ischemic
stroke patients (n = 16) [24]. Their study was a smaller pilot study of acid/base and
electrolyte concentrations at time of thrombectomy and results were not categorized by
sex. Our results demonstrated similar values in both blood samples for pH, Na+ and iCa2+,
in addition to proximal pCO2. However, we found an elevated concentration of oxygen
and lower concentrations in both blood samples for HCO3- and K+, and distal pCO2 in our
results. These differences between the studies could be due to a variety of reasons, such
as thrombectomy technique, handling of samples or patient population. More studies
examining blood collected during thrombectomy will enable answering the causes of the
descrepancies between these first two studies.
Overall, we expected the distal blood to reveal acidosis and hypoxia due to the
blockage of the artery by the cerebral thrombus, however, we did not see those changes
in our results. This may be due to the participant’s cerebrovascular system, collaterals, or
the vessel is not fully occluded by the thrombus. More female than males had collaterals
on presentation to the hospital. A limitation to the study is we did not collect a
comparison CTA collateral score post-thrombectomy to determine the amount of
perfusion the brain regained. Researchers recently evaluated collaterals based on sex in
young, aged, obese, and hypertensive male and female mice [25]. Female mice
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demonstrated smaller infarcts compared to male mice but was not associated with having
greater extent of collaterals or remodeling [25]. An increase in sample size and collection
of long-term imaging will permit a better understanding of the relationship between
collaterals and blood gases during stroke.
Our blood gas results display compensated metabolic acidosis with pH within
normal range, decreased values for pCO2, HCO3-, and base deficit [26, 27]. The majority
of our participants were mechanically ventilated or received supplemental oxygen
throughout the thrombectomy procedure, which is a possible reason for the elevated
oxygen concentration in both the distal and proximal blood samples. Another possibility
is over half of our participants having at least 50% of collaterals on presentation to the
hospital. This increase of intraluminal partial pressure oxygen concentration did not
correlate to a clinical improvement in our participant population showing that other
factors could be accounting for maintenance in acid/base balance.
Hypokalemia and hypocalcemia were seen in both blood samples from our
population. Hypokalemia may be caused by hyperventilation, which often occurs under
anesthesia on a ventilator during mechanical thrombectomy [28]. Another explanation
may be excessive urine loss, prolonged diarrhea, or vomiting, which are commonly seen
in critically ill patients [29]. Hypocalcemia may result from the dilution of plasma seen in
administration of fluid during resuscitative efforts in the ICU [30], in addition to
increased mortality rate in ICU patients [31]. Lower venous total serum calcium
concentrations were associated with more severe clinical symptoms following stroke
onset, worse functional outcomes, and hemorrhagic transformation post-thrombectomy in
ischemic stroke patients [32-34]. Higher venous total serum calcium levels detected
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within 24 hours of stroke onset were associated with better functional outcomes and
reduced cerebral infarcts in acute ischemic patients [35-37].
Limitations
There are several limitations to this study. The sample for this study was small
and mostly Caucasian. This was a non-probability sample based on completed
mechanical thrombectomy procedures. The standard of care includes baseline imaging of
CT and/or MRI upon presentation to the hospital. Based on this imaging, the
neuroradiologist calculates infarct and edema volumes, CTA collateral scores, and
hemorrhagic grade scores. Follow-up imaging is needed to understand how
thrombectomy relates to participant stroke and functional outcomes.
Conclusion
This study is among the first to examine early changes in blood chemistry of acute
ischemic stroke participants who underwent mechanical thrombectomy. As demonstrated
by previous reports, we found differences in the physiological response to stroke between
men and women, which suggests therapeutic approaches may want to take into
consideration sex. Thrombectomy is now a standard of care for ischemic stroke and our
study population is growing. With an increased sample size, more associations could be
elucidated not only based on sex but also co-morbidities and other patient factors relating
to the patient population.
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Table 4.1: Baseline Demographics and Characteristics for Ischemic Stroke Participants.
Males (n = 21)

Females (n = 28)

p value

Age (Years)

67 + 16.54

67 + 14.11

0.961

Ethnicity
African-American
Caucasian
Unknown

1 (4.8)
20 (95.2)
0 (0.0)

2 (7.1)
22 (78.6)
4 (14.3)

0.835
0.099
0.071

7 (33.3)
10 (42.9)
0 (0.0)
4 (19.0)

11 (39.3)
8 (28.6)
3 (10.7)
6 (21.4)

0.762
0.241
0.131
0.904

Comorbidities
Hypertension
Atrial Fibrillation
Diabetes
Hyperlipidemia
Previous Stroke
COPD
CAD

16 (76.2)
7 (33.3)
2 (9.5)
5 (23.8)
4 (19.0)
4 (19.0)
5 (23.8)

21 (75.0)
11 (39.3)
12 (42.9)
9 (32.1)
6 (21.4)
4 (14.3)
1 (3.6)

0.433
0.305
0.004
0.256
0.611
0.746
0.076

Smoking Status
Never
Currently
Previously (> 6 months)

13 (61.9)
6 (28.6)
2 (9.5)

17 (60.7)
6 (21.4)
5 (17.9)

0.933
0.409
0.565

NIHSS on Admission
Minor Stroke (1-4)
Moderate Stroke (5-15)
Moderate/Severe (16-20)
Severe Stroke (≥ 21)

18 + 7.57
3 (14.3)
5 (23.8)
5 (23.8)
8 (38.1)

16 + 6.41
3 (10.7)
10 (35.7)
8 (28.6)
7 (25.0)

0.460
0.706
0.371
0.709
0.325

NIHSS at Discharge
Minor Stroke (1-4)
Moderate Stroke (5-15)
Moderate/Severe (16-20)
Severe Stroke (≥ 21)

12 + 12.34
10 (47.6)
5 (23.8)
3 (14.3)
3 (14.3)

11 + 10.99
11 (39.3)
8 (28.6)
5 (17.9)
4 (14.3)

0.804
0.560
0.709
0.738
0.654

BMI
Under/Normal Weight
Overweight
Obese
Morbidly Obese
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Table 4.1 (continued).
TICI Score
2A = < 50% Perfusion
2B = > 50% Perfusion
3 = Full Perfusion

0 (0.0)
5 (23.8)
16 (76.2)

3 (10.7)
11 (39.3)
13 (46.4)

0.115
0.217
0.075

LKN to Thrombectomy
Completion Time
(minutes)

395.29 + 285.12

533.07 + 254.68

0.081

Infarct Volume (cm3)

81.43 + 97.27

66.30 + 94.07

0.632

Edema Volume (cm3)

70.68 + 97.4

64.71 + 86.34

0.822

Hemorrhagic Grade
None
HI1
H12
PH1
PH2

5 (23.8)
8 (38.1)
7 (33.3)
0 (0.0)
1 (4.8)

6 (21.4)
12 (42.9)
7 (25.0)
2 (7.1)
1 (3.6)

0.838
0.737
0.523
0.211
0.835

CTA Collateral Score
0
1
2
4

10 (47.6)
9 (42.9)
1 (4.8)
0 (0.0)

5 (17.9)
16 (57.1)
4 (14.3)
1 (3.6)

0.027
0.264
0.262
0.375

Values are mean ± SD or (%). Comparisons were performed with independent t-tests,
Chi-square tests based on distribution of data.
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Table 4.2: RM-ANOVA results of sex and blood gas parameters during thrombectomy.
All
Participants (N
= 49)
Mean ± SD

Male (n = 21)
Mean ± SD

Female (n = 28)
Mean ± SD

Distal

7.36 ± 0.06

7.35 ± 0.05

7.38 ± 0.05

0.152

Proximal

7.37 ± 0.06

7.34 ± 0.04

7.39 ± 0.06

0.046

Distal

32.21 ± 5.11

34.70 ± 4.92

30.34 ± 4.96

0.059

Proximal

37.77 ± 3.87

39.60 ± 4.22

36.40 ± 3.87

0.002

Distal

213.98 ± 59.51

209.86 ± 64.12

217.07 ± 56.80

0.779

Proximal

251.43 ± 67.64

233.82 ± 61.10

264.64 ± 61.87

0.427

Distal

-6.28 ± 2.68

-5.83 ± 2.27

-6.65 ± 2.07

0.560

Proximal

-3.85 ± 2.55

-3.89 ± 2.31

-3.82 ± 2.80

0.926

Distal

19.17 ± 2.41

19.38 ± 2.18

19.02 ± 5.66

0.508

Proximal

21.72 ± 2.70

21.54 ± 2.20

21.85 ± 3.06

0.357

Distal

140.47 ± 4.66

140.19 ± 4.09

140.68 ± 4.11

0.748

Proximal

138.45 ± 3.20

138.62 ± 1.91

138.32 ± 3.94

0.777

Distal

3.04 ± 0.86

3.24 ± 0.82

2.88 ± 0.87

0.116

Proximal

3.46 ± 0.47

3.66 ± 0.42

3.31 ± 0.46

0.004

Parameters

Pvalue

pH

pCO2 (mmHg)

pO2 (mmHg)

BD (mmol/L)

HCO3- (mmol/L)

Na+ (mmol/L)

K+ (mmol/L)
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Table 4.2 (continued).
iCa2+ (mg/dL)
Distal

3.86 ± 0.79

3.94 ± 0.75

3.81 ± 0.83

0.552

Proximal

4.33 ± 0.22

4.32 ± 0.25

4.34 ± 0.20

0.994

Data are presented as mean ± standard deviations. pCO2: Partial pressure of carbon
dioxide (mmHg); pO2: partial pressure of oxygen (mmHg); HCO3-: bicarbonate
(mmol/L); BD: base deficit (mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation
(%); Na+: sodium (mmol/L); K+: potassium (mmol/L); iCa2+: ionized calcium (mmol/L).
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Table 4.3: Moderated Multiple Regression Variables Predicting Infarct Volume (n = 49)
Variable

B

SE B

β

P value

Age

-1.56

1.22

-0.245

0.213

DK+ x sex

-78.86

74.20

-0.491

0.296

DBD x sex

-14.30

12.30

-0.537

0.254

Abbreviations: K+: potassium (mmol/L); and BD: base deficit (mmol/L).
These were the remaining variables in the model with VIF < 10.
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Table 4.4: Moderated Multiple Regression Variables Predicting Edema Volume (n = 49)
Variable

B

SE B

β

P value

Age

-1.18

1.31

-0.177

0.377

DK+ x sex

-83.33

77.49

-0.502

0.291

DBD x sex

-16.11

12.87

-0.584

0.220

Abbreviations: K+: potassium (mmol/L); and BD: base deficit (mmol/L).
These were the remaining variables in the model with VIF < 10.
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Table 4.5: Moderated Multiple Regression Variables Predicting Infarct Time (n = 49)
Variable

B

SE B

β

P value

Age

0.65

2.69

0.38

0.037

DHCO3- x sex

37.81

18.15

0.55

0.019

DBD x sex

37.50

15.40

0.47

0.044

R2 = 0.18, adjusted R2 = 0.12, df = 4, F = 3.023, Durbin-Watson = 1.918
Abbreviations: HCO3-: bicarbonate (mmol/L); and BD: base deficit (mmol/L).

Copyright © Sarah R. Martha 2019
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CHAPTER 5. DISCUSSION AND CONCLUSIONS
Background and Purpose
Given that ischemic stroke is the leading cause of disability in the United States,
the need to refine and develop innovative treatments remains a pressing priority for
medical researchers. Nurse researchers can contribute to these efforts by bridging the gap
between clinical and bench science, and harnessing their knowledge of patient
experiences to assist in the creation of multi-disciplinary studies. This dissertation
emerges from such a collaboration and contributes to the effort to expand the field of
nursing research interest in neuropathology and quantitative research.
The purpose of this dissertation was to examine neurochemical factors associated
with the initial pathophysiological reaction to acute large vessel occlusion in rodent
models and individuals diagnosed with ischemic stroke. Three studies were conducted
focused on acid/base and electrolyte concentrations in these populations: 1) a descriptive
correlational analysis of the associations between venous blood gases, infarct volume and
mortality in young male (three month old) Sprague Dawley rats; 2) a descriptive
correlational analysis of the relationship between venous blood gases to infarct and
edema volumes, and mortality in aged (18 months old) male and female Sprague Dawley
rats; 3) a descriptive correlational study comparing acid/base and electrolyte
concentrations in patients diagnosed with ischemic stroke who underwent mechanical
thrombectomy.
This chapter will present a summary of the findings from the three manuscipts. I
will then synthesize those findings to explain how the results help further our
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understanding of the neurochemical changes that take place during stroke.
Recomendations for future research will be addressed, as will limitations both of the
current study and existing efforts to study ischemic stroke.
Summary of Findings
In Chapter Two, we examined the differences between acid/base balance and
electrolyte concentrations in two focal ischemia models in young male rats. This was a
descriptive correlational study evaluating three-month old Sprague-Dawley male rats that
underwent permanent (n = 18) or transient (n = 19) middle cerebral artery occlusion
(MCAO). Pre- and post-MCAO venous blood samples from permanent and transient
models provided pH, carbon dioxide (CO2), oxygen (O2) , bicarbonate (HCO3-), glucose,
hemoglobin, hematocrit, and electrolyte values of ionized calcium (iCa2+), potassium
(K+) and sodium (Na+). Mean differences were seen in the blood gas and electrolyte
concentrations between pre- to post-MCAO in both models. pH and iCa2+ were
predictors of infarct volume in the permanent MCAO model. The transient MCAO model
exhibited greater survival to 72 hours compared to the permanent MCAO model (p =
0.045).
In Chapter Three, we compared acid/base balance and electrolyte concentrations
at three time points between aged male and female rats. We examined venous blood gas
samples of aged (18 month old) Sprague Dawley male (n = 15) and female (n = 16) rats
1) pre-, 2) post-, and 3) at 72 hours of permanent MCAO. The repeated measures
ANOVA revealed no mean differences in acid/base and electrolyte concentrations from
the three time points between the sexes. However, changes in pH (from pre- to postMCAO and post-MCAO to 72 hours) and changes in Na+ and iCa2+ (from post-MCAO to
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72 hours) were predictors of infarct volume and edema volume, respectively. There was a
3.25 times increased risk for mortality in rats based on changes (cut-off range within 2.00 to -7.00) in HCO3- levels (pre- to post-MCAO).
In Chapter Four, we compared acid/base balance and electrolyte concentrations in
arterial distal and proximal blood to the cerebral thrombus between male (n = 21) and
female (n = 28) ischemic stroke participants who underwent mechanical thrombectomy.
On average female participants had a two and half hour increase in time from ischemic
stroke symptom onset to vessel recanalization or infarct time compared to male
counterparts. Changes in HCO3- and base deficit were found to be predictors of infarct
time, but only in females.
Implication of Findings
The results from this dissertation have expanded our understanding of
neurochemical factors and neuropathology at the time of focal ischemia in rats and
patients with ischemic stroke at the time of mechanical thrombectomy in a number of
ways:
1) In examining two different rodent models (permanent MCAO and transient
MCAO), we were able to compare baseline blood gas values to blood gas values taken
immediately after the occlusion. First, because the majority of stroke patients do not
receive tPA and/or mechanical thrombectomy, this comparison in the permanent MCAO
model is important because it reveals insights about the speed at which neurochemical
changes take place. Second, the transient MCAO model resembles recanalization and
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reperfusion of the artery and allows us to examine blood chemistry changes that occur in
the brain after treatment.
2) In examining young male and aged male and female rats, we have identified
predictors of infarct volume, edema volume, and mortality in an animal model. This
insight is novel because there is no existing research of acid/base and electrolytes
concentrations as predictors of stroke, let alone at this early phase of stroke onset. This
gives us an insights about the speed at which neurochemical changes are taking place.
This is something we can observe in rodent models but which could aid us in
understanding what occurs in patients who have an ischemic stroke.
3) We are among only a few researchers to compare acid/base and electrolytes
from blood distal and proximal to the cerebral thrombus in patients after ischemic stroke.
The protocol developed for the Blood and Clot Thrombectomy Registry and
Collaboration (BACTRAC) study uses an innovative method to obtain blood specimens
and allows for a systematic understanding of ischemic stroke neuropathology at the time
of mechanical thrombectomy. Our results challenge the current literature by
demonstrating that a compensated metabolic acidosis with an elevated oxygen
concentration appeared in the distal blood. Future studies should aim to identify the
percentage of arterial occlusion that occurred in patients undergoing thrombectomy,
ventilator settings during thrombectomy, and the amount of the time the patient was
provided supplemental oxygen. In understanding and improving stroke outcomes,
investigators should evaluate and compare arterial blood gases not only during
thrombectomy but across several points during the patient’s hospital stay and the
relationship to functional outcomes.
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4) By examining sex differences in acid/base and electrolyte concentrations in
patients, we discovered significant differences in the proximal blood in patients
diagnosed with ischemic stroke. In females, we found that changes in bicarbonate and
base deficit were predictors of infarct time. Additionally, in females, there was
approximately 2.5 hour increase from symptom onset to thrombectomy completion time
compared with males. In our study population, more males than females displayed absent
collaterals on presentation to the hospital. Sex differences are generally ignored in
clinical trials for stroke therapies and our results suggest a renewed importance in
considering how differences in treatment times affect overall outcomes for female
patients. Future studies should aim to identify different parameters to determine stroke
outcomes based on sex. Investigators should focus on factors like distance and time from
LKN to the hospital, marriage status, insurance status, imaging issues, and delay in
hospital diagnosis.
Limitations
Emergent large vessel occlusion (ELVO) accounts for 20-40% of ischemic
strokes and is the most disabling form of stroke [1-3]. Nevertheless, our understanding of
stroke pathophysiology remains limited due to the challenges of studying stroke onset in
humans. Animal models, particularly young rodents, have long served as a way for
researchers to model stroke pathophysiology, yet stroke research has, on the whole,
suffered an inability to provide clinically relevant animal-to-human translation. This is
due in part to how animal studies are conducted, which typically follows a uniform
practice of selecting young male rodents as its test subjects. The majority of ELVO stroke
patients are middle-aged to elderly and are of both sexes, revealing that there is an age
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and sex mismatch between ischemic stroke patients and animal models. Rethinking of the
experimental animal models needs is required, especially in encouraging the use of aged
male and female rats with comorbidities to more closely mirror human populations.
A limitation for Chapters Two and Three is venous blood samples were not
always obtained pre-, post-, and/or at 72 hours of MCAO procedure and therefore
reduced the number of samples in analyses. We have identified several issues with the
collection of blood samples, faulty iSTAT cartridges, air bubbles in blood, fragile
vasculature of aged animals were fragile and IJ collapsed, and/or insufficient amount of
blood drawn. Working with aged animals is challenging. Post-MCAO we had
approximately 50% mortality rate decreasing our sample size, especially in aged female
rats. We believe this is due to the aging vasculature of the animals.
Another limitation with our human study is the nature and complexity of Blood
and Clot Thrombectomy Registry and Collaboration (BACTRAC) study. BACTRAC is a
multidisciplinary team operating in a clinical environment, and therefore, the potential
data collection and specimen processing errors occurred. Additionally, the potential for
sampling bias was present since the sampling strategy was purposeful, non-probability
sample, and based on number of thrombectomy procedures completed. The current
patient population used in this study is largely Caucasian and limited to the hospital’s
location in Central Kentucky. A larger and more diverse sample size is needed. An
additional limitation is that we could not control for all comorbidities present in our
sample population of ischemic stroke participants.
The BACTRAC study data are limited to the patient’s hospitalization, limiting our
ability to study long-term impact on functional outcomes. The two blood samples
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(proximal and distal) were drawn at approximately the same time during mechanical
thrombectomy. Thus, it was not possible to compare across time points and longitudinal
data is needed for a systematic understanding of changes. Additionally, imaging for the
infarct and edema volumes were based on CT and/or MRI that was completed prior to
thrombectomy. Based on this initial imaging, CTA scores and hemorrhagic grade scores
were assigned. However, even though this is the standard of care, there is no long-term
follow-up or re-evaluation to understand how the treatment relates to these outcomes.
Recommendations for Future Research
Future studies are needed to identify serum biomarkers to predict the risk of
worsened long-term outcomes and/or increased risk for mortality. Mechanical
thrombectomy provides a unique opportunity for researchers to further this work by
expanding the collection and analysis of biospecimens (distal blood, proximal blood, and
cerebral thrombus). To understand the complexity of stroke, researchers can analyze
these tissues for different molecular targets (such as proteomics and genomics) that occur
in response to ischemic stroke. Associations may be found between patient characteristics
(based on comorbidities, age, and sex) and functional recovery. This information may aid
in the reduction of symptom burden for individuals diagnosed with ischemic stroke.
Investigators should also focus on data from ischemic stroke patients and attempt to
discover target molecules and then in animals to establish mechanism, this will aid in the
development of new stroke therapies, keeping in mind that sex differences may play a
role in treatment success. Finally, researchers must begin to explore how patients’
respond to thrombectomy through long-term studies with ischemic stroke survivors and
evaluation of their functional outcomes.
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